Repressor-mediated regulation system for control of gene expression in plants

ABSTRACT

The invention provides a method for selectively controlling the transcription of a gene of interest, comprising producing one or more plants that express either a first, a second, or both the first and second genetic constructs. The first genetic construct comprises a first regulatory region operatively linked to a gene of interest and at least one repressor sequence capable of controlling the activity of the first regulatory region. The second genetic construct comprises a second regulatory region in operative association with a nucleic acid molecule, or a derivative thereof, encoding a repressor protein, the repressor protein exhibiting both repressor operator sequence binding activity and repressor activity. The first and second genetic constructs may reside on separate vectors, or the vector may comprise both the first and second genetic constructs comprised as just defined. If the first and second constructs reside within separate plants, then the first plant and the second plant are crossed to obtain progeny, so that the progeny comprise both the first genetic construct and the second genetic construct. The progeny of this cross are characterized in that the expression of the second genetic construct represses expression of the gene of interest. The first and second regulatory regions may be either the same or different and may be selected from the group consisting of a constitutive promoter, an inducible promoter, a tissue specific promoter, and a developmental promoter. If the plant comprises the vector that comprises both the first and second genetic construct, or if a plant has been co-transformed with the first and second genetic construct so that both the first and second genetic constructs may be expressed in the same plant, then it is preferred that the first and second regulatory regions are different. The first regulatory region may comprise a constitutive promoter, an inducible promoter, a tissue specific promoter, or a developmental promoter. The second regulatory region may comprise an inducible promoter, a tissue specific promoter, or a developmental promoter.

The present invention relates to the regulation of gene expression. Moreparticularly, the present invention pertains to the control of geneexpression of one or more nucleotide sequences of interest in transgenicplants using a repressor protein and corresponding operator sequences.

BACKGROUND OF THE INVENTION

Transgenic plants have been an integral component of advances made inagricultural biotechnology. They are necessary tools for the productionof plants exhibiting desirable traits (e.g. herbicide and insectresistance, drought and cold tolerance), or producing products ofnutritional or pharmaceutical importance. As the applications oftransgenic plants become ever more sophisticated, it is becomingincreasingly necessary to develop strategies to fine-tune the expressionof introduced genes. The ability to tightly regulate the expression oftransgenes is important to address many safety, regulatory and practicalissues. To this end, it is necessary to develop tools and strategies toregulate the expression of transgenes in a predictable manner.

Several strategies have so far been employed to control plantgene/transgene expression. These include the use of regulated promoters,such as inducible or developmental promoters, whereby the expression ofgenes of interest is driven by promoters responsive to variousregulatory factors (Gatz, 1997, Ann. Rev. Plant Physiol. Plant Mol.Biol., 48: 89). Other strategies involve co-suppression (Eisner et al.,1998, Ther. Appl. Genet:, 97: 801) or anti-sense technology(Kohno-Murase et al., 1994, Plant Mol. Biol., 26: 1115), whereby plantsare transformed with genes, or fragments thereof, that are homologous togenes either in the sense or antisense orientations. Chimeric RNA-DNAoligonucleotides have also been used to block the expression of targetgenes in plants (Beetham et al., 1999, Proc. Natl. Acad. Sci. USA, 96:8774; Zhu et al., 1999, Proc. Natl. Acad. Sci. USA, 96: 8768).

The ROS protein is encoded by the chromosomal gene, ROS, ofAgrobacterium tumefaciens. In this organism, the ROS protein acts as anegative regulator for the expression of the Ti-plasmid-encoded VirC,VirD and IPT genes (Cooley et al., J. 1991, Bacteriol. 173: 2608-2616;Chou et al., 1998, Proc. Natl. Acad. Sci., 95: 5293; Archdeacon J et al.2000, FEMS Microbiol Let. 187: 175-178; D'Souza-Ault M. R., 1993, JBacteriol 175: 3486-3490). The ROS protein is a DNA binding protein thatis able to bind a ROS operator sequence (D'Souza-Ault M. R., 1993, JBacteriol 175: 3486-3490).

Analysis of the amino acid sequence of the ROS protein reveals that ithas a DNA binding motif of the C₂H₂ zinc finger configuration (Chou etal., 1998, Proc. Natl. Acad. Sci., 95: 5293). Typical zinc fingers arecharacterised by the presence of two cysteine and two histidine residuesjoined together by the coordination of a single zinc ion. A stretch ofamino acids forms a peptide loop, known as the zinc finger motif that isrequired for DNA binding. Zinc finger proteins represent a significantportion of proteins in eukaryotes, but are rare in prokaryotes. The zincfinger of the bacterial ROS protein varies from its counterparts ineukaryotes in that the ROS protein has only one zinc finger motif, whileeukaryotic zinc finger proteins have multiple zinc finger motifs. Inaddition, there are 9 amino acid residues making up the peptide loopspacing the zinc finger motif in the ROS protein as compared to the 12amino acids that make up the loops of zinc fingers of eukaryoticproteins.

There is no suggestion for the use of ROS repressor to regulate geneexpression within plants. The present invention provides a method forthe regulation of gene expression in plants using a nucleic acidsequence, or derivatives of thereof, that encode ROS.

It is an object of the invention to overcome disadvantages of the priorart.

The above object is met by the combinations of features of the mainclaims, the sub-claims disclose further advantageous embodiments of theinvention.

SUMMARY OF THE INVENTION

The present invention relates to the regulation of gene expression. Moreparticularly, the present invention pertains to the control of geneexpression of one or more nucleotide sequences of interest in transgenicplants using a repressor protein and corresponding operator sequences.

According to the present invention there is provided a method (A) forselectively controlling the transcription of a gene of interest,comprising:

-   -   i) producing a first plant comprising a first genetic construct,        the first genetic construct comprising a first regulatory region        operatively linked to a gene of interest and at least one        repressor operator sequence capable of controlling the activity        of the first regulatory region;    -   ii) producing a second plant comprising a second genetic        construct, the second genetic construct comprising a second        regulatory region in operative association with a nucleic the        molecule, or a derivative thereof, encoding a repressor, the        repressor exhibiting both repressor operator binding activity        and repressor activity;    -   iii) crossing the first plant and the second plant to obtain        progeny, the progeny comprising both the first genetic construct        and the second genetic construct, and characterized in that the        expression of the second genetic construct represses expression        of the gene of interest.        It is preferred that the gene encoding the repressor is        optimized for expression in the plant, and that the gene encodes        a nuclear localization signal. Furthermore, it is preferred that        the repressor is a ROS repressor, and the repressor operator        sequence is a ROS operator sequence.

The present invention also embraces the above method (A), wherein thefirst and second regulatory regions are either the same or different andare selected from the group consisting of a constitutive promoter, aninducible promoter, a tissue specific promoter, and a developmentalpromoter.

The present invention further provides a method (B) for selectivelycontrolling the transcription of a gene of interest in a plant,comprising:

-   -   i) introducing into the plant either separately, or within the        same vector:        -   a) a first genetic construct comprising a nucleic acid            molecule comprising a first regulatory region operatively            linked to a gene of interest, and at least one ROS operator            sequence capable of controlling the activity of the first            regulatory region; and        -   b) a second genetic construct comprising a second regulatory            region in operative association with a nucleotide sequence            encoding a ROS repressor, or a derivative thereof, said ROS            repressor exhibiting ROS operator binding activity, ROS            repressor activity or both ROS operator binding activity and            ROS repressor activity, the second regulatory region            comprises an inducible promoter,    -   ii) growing the plant, and    -   iii) inducing the activity of said inducible promoter so that        expression of the second genetic construct produces the ROS        repressor and represses expression of the gene of interest.        It is preferred that the gene encoding the repressor is        optimized for expression in the plant, and that the gene encodes        a nuclear localization signal. Furthermore, it is preferred that        the repressor is a ROS repressor, and the repressor operator        sequence is a ROS operator sequence.

The present invention embraces a method (C) for selectively controllingthe transcription of a gene of interest in a plant, comprising:

-   -   i) introducing into the plant either separately, or within the        same vector::        -   a) a first genetic construct comprising a nucleic acid            molecule comprising a first regulatory region operatively            linked to a gene of interest, and at least one ROS operator            sequence capable of controlling the activity of the first            regulatory region; and        -   b) a second genetic construct comprising a second regulatory            region in operative association with a nucleotide sequence            encoding a ROS repressor, or a derivative thereof, said ROS            repressor exhibiting ROS operator binding activity, ROS            repressor activity, or both ROS operator binding activity            ROS repressor activity, the second regulatory region            comprises a tissue specific promoter; and    -   ii) growing said plant, so that expression of said second        genetic construct produces said ROS repressor and represses        expression of said gene of interest in a tissue specific manner.        It is preferred that the gene encoding the repressor is        optimized for expression in the plant, and that the gene encodes        a nuclear localization signal. Furthermore, it is preferred that        the repressor is a ROS repressor, and the repressor operator        sequence is a ROS operator sequence.

The present invention also provides a method (D) for selectivelycontrolling the transcription of a gene of interest in a plant,comprising:

-   -   i) introducing into the plant either separately, or within the        same vector:        -   a) a first genetic construct comprising a nucleic acid            molecule comprising a first regulatory region operatively            linked to a gene of interest, and at least one ROS operator            sequence capable of controlling the activity of the first            regulatory region; and        -   b) a second genetic construct comprising a second regulatory            region in operative association with a nucleotide sequence            encoding a ROS repressor, or a derivative thereof, said ROS            repressor exhibiting ROS operator binding activity, ROS            repressor activity, or both ROS operator binding activity            ROS repressor activity; second regulatory region comprises a            promoter that is active at one or more specific            developmental stages within the plant; and    -   ii) growing the plant so that the activity of the promoter at        one or more specific developmental stages within the plant        results in expression of the second genetic construct thereby        producing said ROS repressor, and represses expression of the        gene of interest.        It is preferred that the gene encoding the repressor is        optimized for expression in the plant, and that the gene encodes        a nuclear localization signal. Furthermore, it is preferred that        the repressor is a ROS repressor, and the repressor operator        sequence is a ROS operator sequence.

The present invention is also directed to a nucleic acid molecule, or aderivative thereof, encoding a ROS repressor optimized for plant codonusage and exhibiting both ROS operator binding activity and ROSrepressor activity. The nucleic acid molecule or a derivative thereof,maybe characterized as comprising one or more of the followingproperties:

-   -   a) comprising greater than 80% similarity with the nucleotide        sequence of SEQ ID NO:2 or 3 as determined by use of the BLAST        algorithm with the following. parameters: blastn; Database: nr;        Expect 10; filter: low complexity; Alignment: pairwise; Word        Size: 11;    -   b) hybridizing under stringent conditions with the nucleotide        sequence of SEQ ID NO:2 or 3, comprising hybridizing for 16-20        hrs at 65° C. in 7% SDS, 1 mM EDTA, 0.5M Na₂HPO₄, pH 7.2,        followed by washing in 5% SDS, 1 mM EDTA 40 mM Na2HPO₄, pH 7.2        for 30 min, followed by washing in 1% SDS, 1 mM EDTA 40 mM        Na2HPO₄, pH 7.2 for 30 min;    -   c) comprising the nucleotide sequence of SEQ ID NO:2; and    -   d) comprising the nucleotide sequence of SEQ ID NO:3.

Furthermore, the present invention relates to a genetic constructcomprising a regulatory region in operative association with the nucleicacid molecule as defined above, and to a plant, or seed comprising thegenetic construct.

The present invention also pertains to a nucleic acid molecule asdefined above, further comprising a nuclear localization signal fused tothe nucleic acid molecule, and to a genetic construct comprising anuclear localization signal fused to the nucleic acid molecule asdefined above. The present invention includes, a plant, or seedcomprising the genetic construct as just defined.

The present invention further relates to a nucleic acid moleculecomprising a regulatory region operatively linked to a gene of interestand at least one ROS operator sequence capable of controlling theactivity of the regulatory region, wherein the regulatory region isfunctional in plants. Preferably, the at least one ROS operator sequencecomprises the nucleotide sequence of SEQ ID NO:8. This invention alsoprovides a genetic construct comprising the nucleic acid molecule asjust defined, and to a plant comprising the genetic construct.

The present invention also pertains to a plant comprising a firstgenetic construct comprising a first nucleic acid molecule comprising afirst regulatory region operatively linked to a gene of interest, and atleast one ROS operator sequence capable of controlling the activity ofthe first regulatory region, and a second genetic construct comprising asecond nucleic acid molecule, or a derivative thereof, encoding a ROSrepressor optimized for plant codon usage and exhibiting ROS operatorbinding activity, ROS repressor activity, or both ROS operator bindingactivity ROS repressor activity.

This summary of the invention does not necessarily describe allnecessary features of the invention but that the invention may alsoreside in a sub-combination of the described features.

BRIEF DESCRIPTION OF THE DRAWINGS

These and other features of the invention will become more apparent fromthe following description in which reference is made to the appendeddrawings wherein:

FIG. 1 shows the nucleotide and deduced amino acid sequences of wildtype ROS and a modified ROS of Agrobacterium tumefaciens. FIG. 1(A)shows the amino acid sequence alignment of known ROS repressors (SEQ IDNOs:26,28,29,30), and a synthetic ROS (SEQ ID NO:27). The amino acidsequence ‘PKKKRKV’ at the carboxy end of synthetic ROS is one of severalnuclear localization signals. FIG. 1(B) shows the nucleotide sequence ofa synthetic ROS that had been optimized for plant codon usage containinga nuclear localization signal peptide (in italics). Optional restrictionsites at the 5′ end of the sequence are underlined (also see SEQ IDNO:2). FIG. 1(C) shows the consensus nucleotide (SEQ ID NO:3) andpredicted amino acid sequence, of a composite ROS sequence comprisingall possible nucleotide sequences that encode wild type ROS repressor,and the wild type ROS amino acid sequence. The amino acid sequence‘PKKKRKV’ at the carboxy end represents a nuclear localization signal.Amino acids in bold identify the zinc finger motif.

Nucleotide codes are as follows: N=A or C or T or G; R=A or G;Y=C or T;M=A or C; K=T or G; S=C or G; W=A or T; H=A or T or C; B=T or C or G;D=A or T or G; V=A or C or G. FIG. 1(D) shows the nucleotide sequence ofthe DNA binding sites (operator sequences) of the virC/virD and iptgenes. FIG. 1(E) shows a consensus operator sequence derived from thevirC/virD and ipt operator sequences (SEQ ID NO:20). This sequencecomprises 10 nucleotides, however, only the first 9 nucleotides arerequired for binding ROS.

FIG. 2 displays the structure of various constructs in which thetranscription of a modified ROS or wild type ROS nucleotide sequence isplaced under control of various regulatory regions. The modified ROSnucleotide sequence is designated as ‘synthetic ROS’. FIG. 2(A) shows aschematic diagram of the p74-107 nucleotide construct in which a CaMV35Sregulatory region is operatively linked to the wild type ROS proteincoding region. FIG. 2(B) shows the nucleotide construct p74-313 in whicha CaMV35S regulatory region is operatively linked (transcriptionallyfused) to the protein coding region of synthetic ROS. FIG. 2(C) showsthe nucleotide construct p74-108 in which a trns2 regulatory region istranscriptionally fused to the protein coding region of synthetic ROS.FIG. 2(D) shows the nucleotide construct p74-101 in which an actin2regulatory region is operatively linked to the protein coding region ofsynthetic ROS.

FIG. 3 shows schematic representations of nucleotide constructs thatplace the expression of a gene of interest under the control aregulatory region, in this case a CaMV35S regulatory region, modified tocontain a ROS operator site. FIG. 3(A) shows the nucleotide constructp74-315 in which a CaMV35S regulatory region, modified to contain a ROSoperator site downstream of the TATA box, is operatively linked to agene of interest (β-glucuronidase; GUS). FIG. 3(B) shows the nucleotideconstruct p74-316 in which a CaMV35S regulatory region is modified tocontain a ROS operator site upstream of the TATA box is operativelylinked to the protein encoding region of GUS. FIG. 3(C) shows thenucleotide construct p74-309 in which a CaMV35S regulatory regionmodified to contain ROS operator sites upstream and downstream of theTATA box is transcriptionally fused (i.e. operatively linked) to theprotein encoding region of GUS.

FIG. 4 shows a schematic representation of a nucleotide construct thatplaces the expression of a gene of interest gene under the control of aregulatory region, in this case, the tms2 regulatory region that hasbeen modified to contain ROS operator sites. FIG. 4(A) shows thenucleotide construct p76-507 in which a tms2 regulatory region isoperatively linked to a gene of interest (in this case encodingβ-glucuronidase, GUS). FIG. 4(B) shows the nucleotide construct p76-508in which a tms2 regulatory region modified to contain two tandemlyrepeated ROS operator sites downstream of the TATA box istranscriptionally fused (i.e. operatively linked) to the protein codingregion of GUS.

FIG. 5 shows a schematic representation of a nucleotide construct thatplaces the expression of a gene of interest under the control of aregulatory region, in this case actin 2 regulatory region, that has beenmodified to contain ROS operator sites. FIG. 5(A) shows the nucleotideconstruct p75-101 in which an actin2 regulatory region is operativelylinked to a gene of interest (the β-glucuronidase (GUS) reporter gene).FIG. 5(B) shows the nucleotide construct p74-501 in which an actin2regulatory region modified to contain two tandemly repeated ROS operatorsites upstream of the TATA box is transcriptionally fused (operativelylinked) to the a gene of interest (GUS). FIG. 5C shows construct p74-118comprising a 35S regulatory region with three ROS operator sitesdownstream from the TATA box. The 35S regulatory region is operativelylinked to the gene of interest (GUS).

FIG. 6 shows Southern analysis of transgenic Arabidopsis plants. FIG.6(A) shows Southern analysis of a plant comprising a first geneticconstruct, p74-309 (35S-operator sequence-GUS; see FIG. 3(C) for map).FIG. 6(B) shows Southern analysis of a plant comprising a second geneticconstruct, p74-101 (acti-synthetic ROS; see FIG. 2(D) for map).

FIG. 7 shows Westerns analysis of ROS expression in transformedArabidopsis plants. Levels of wild type ROS, p7⁴-107 (35S-WTROS; seeFIG. 2(A) for map), and synthetic ROS p74-101 (actin2-synROS; see FIG.2(D) for map) produced in transgenic plants were determined by Westernanalysis using a ROS polyclonal antibody. Arabidopsis var. columbia, wasrun as a control.

FIG. 8 shows expression of a gene of interest in plants. Upper panelshows expression of GUS under the control of 35S (pBI121; 35S:GUS).Middle panel shows GUS expression under the control of actin2 coprisingROS operator sequences (p74-501; see FIG. 5(B) for construct). Lowerpanel shows the lack of GUS activity in a non-transformed control.

FIG. 9 shows regulation of a gene of interest in progeny plants arisingfrom a cross between a ROS parent plant (expressing p74-101, FIG. 2D;and example of a second nucleotide sequence) and a plant expressing agene of interest under the control of a regulatory region comprising ROSoperator sequences (GUS parent expressing p74-118, FIG. 5C; and exampleof a first nucleotide sequence). FIG. 9A shows GUS activity in the ROSand GUS parents and the progeny obtained from the cross of the ROS andGUS parents. FIG. 9B shows Northern analysis of RNA obtained from ROSand GUS parents and the progeny of the cross between the ROS and GUSparents and probed with either a ROS or GUS probe. FIG. 9C showsSouthern analysis of the progeny of the cross between the GUS and ROSparent plants, probed with either a GUS or ROS probe.

FIG. 10 shows several non-limiting examples of constructs of the presentinvention, that and referred to FIG. 11. FIG. 10A shows two non-limitingexamples of a second nucleotide sequence (repressor construct), p74-101(Actin2 promoter-synRos) and p74-313 (35S promoter-synRos). FIG. 10Bshows several non-limiting examples of a first nucleotide sequence((reporter constructs) including p74-316 (35S-1xOS-GUS; the OS is placedprior to the TATA sequence), p74-118 (35S-3xOS-GUS; all OS's after TATAsequence), p74-117 (35S-3xOS-GUS; one OS placed prior to TATA sequence),p74-501 (Actin 2-1xOS-GUS; OS placed prior to TATA sequence). Theoperator sequence (OS) is shown as a filled oval.

FIG. 11 shows Northern analysis and GUS activity of several parentallines, and progeny from crosses of parental lines expressing a first anda second nucleotide sequence. In FIGS. 11A-C, total RNA (˜4.5g) wasisolated from Arabidopsis parental lines comprising a first nucleotidesequence, expressing a gene of interest, in this case GUS (lanes markedGUS), a second nucleotide sequence, expressing synRos (lanes markedROS), and crosses between various combinations of parental lines (C1-C5;see FIG. 10 for constructs) as follows: Constucts Parental lines CrossesFemale X male Female X male parent Cross1(C1) 74-316 X 74-101 P1GUS XP1ROS Cross2(C2) 74-101 X 74-117 P2ROS X P2GUS Cross3(C3) 74-118 X74-101 P3GUS X P3ROS Cross4(C4) 74-117 X 74-101 P2GUS X P2ROS Cross5(C5)74-313 X 74-501 P5ROS X P5GUSParental transgenic plants, and progeny arising from the crosses, wereanalyzed for GUS, using a GUS probe (FIG. 11A), and synROS, using a ROSprobe (FIG. 11B), expression. FIG. 11C shows the loading of the RNA gelused for FIGS. 11A and B. FIG. 11D shows quantification of the densitiesof bands generated by Northern blot analysis of total RNA and probedwith GUS as shown in FIG. 11A. B1 and B2 are blank (background) samples.Plant lines are as indicated in the Table above. Band intensity wascalculated using Quantity One Software (Biorad).

FIG. 12 shows non-limiting examples of a first nucleotide sequence and asecond nucleotide sequence of the invention. FIG. 12A shows thestructure of the p74-101 repressor construct (a second nucleotidesequence also described in FIG. 2D) in which an actin2 regulatory regionis operatively linked to a protein coding region of synthetic ROS. FIG.12B shows the structure of the p74-114 reporter construct (a firstnucleotide sequence) in which a CaMV35S regulatory region, modified tocontain 4 ROS operator sequences, is operatively linked to a proteinencoding region of GUS. An operator sequence (OS) is shown as a filledoval with one OS upstream and three OS downstream of a TATA Boxsequence.

FIG. 13 shows Northern blot analysis of total RNA isolated from Brassicanapus reporter/repressor crosses and parental lines. In FIGS. 13A-Ctransgenic B. napus plants were crossed and analyzed for expressionlevels of both GUS and ROS genes. The -female parent is indicated first.Crosses performed are as follows: C1 and C2 are p74-114xp74-101. P1GUSis GUS parent plant for cross 1. P2GUS is GUS parent plant for cross2.PROS is ROS parent plant for crosses C1 and C2. FIG. 13A shows RNAloaded on a gel (approximately 4.5 ug of total RNA loaded per lane)prior to probing with GUS and synthetic ROS nucleic acid probes. FIG.13B shows expression levels of crosses and parental lines probed withGUS (top) and synthetic ROS (bottom). FIG. 13C shows quantification ofthe densities of bands generated by northern blot analysis as shown inFIG. 13B. Plant lines are as indicated in FIG. 13A and B. Band intensitywas measured using Quantity One Software (Biorad).

DESCRIPTION OF PREFERRED EMBODIMENT

The present invention relates to the regulation of gene expression. Moreparticularly, the present invention pertains to the control of geneexpression of one or more nucleotide sequences of interest in transgenicplants using a repressor protein and corresponding operator sequences.

The following description is of a preferred embodiment byway of exampleonly and without limitation to the combination of features necessary forcarrying the invention into effect.

Gene repression can be used in applications such as metabolicengineering to produce plants that accumulate large amounts of certainintermediate compounds. Repression of gene expression can also be usedfor control of transgenes across generations, or production of F1 hybridplants with seed characteristics that would be undesirable in theparental line, for example but not limited to, hyper-high oil, reducedfiber content low glucosinolate levels, reduced levels of phytotoxins,and the like. In the latter examples, low glucosinolate levels, or otherphytotoxins, may be desired in seeds while higher concentrations ofthese compounds maybe required elsewhere, for example in the case ofglucosinolates, within cotyledons, due to their role in plant defence.Another non-limiting example for the controlled regulation of a gene ofinterest during plant development is seed specific down regulation ofsinapine biosynthesis, as for example in seeds of Brasicca napus. Inmany instances, transgene expression needs to be repressed only incertain plant organs/tissues or at certain stages of development. Themethods as described herein may also be used to control the expressionof a gene of interest that encodes a protein used to for plant selectionpurposes. For example, which is to be considered non-limiting, a gene ofinterest may encode a protein that is capable of metabolizing a compoundfrom a non-toxic form to a toxic form thereby selectively removingplants that express the gene of interest.

The present invention is directed to a method of controlling geneexpression using a repressor protein as a regulatory switch to repressthe expression of a gene or coding region of interest, or repress thetranscription of one, or more than one, selected nucleotide sequences bytransforming a plant with one, or more than one, constructs comprising:

1) a first nucleotide sequence comprising a gene(or coding region) ofinterest operatively linked to a regulatory region comprising at leastone repressor operator sequence that interacts with a repressor protein.

2) a second nucleotide sequence comprising a regulatory region inoperative association with a nucleotide sequence encoding the repressorprotein.

Preferably the repressor protein is ROS, and the repressor operatorsequence is a ROS repressor operator sequence, for example but notlimited to the ROS reporessor encoded by the nucleic acid sequence ofSEQ ID NO:3.

These first and second nucleotide sequences may be placed within thesame or within different vectors, genetic constructs, or nucleic acidmolecules. When both constructs are expressed within the same plant, theexpression of the repressor protein results in the down regulation inthe expression of a gene (or coding region) of interest that is inoperative association, or operatively linked, with an operator sequencethat exhibits an affinity for the repressor protein. By “operativelyassociation” or “operatively linked” it is meant that the particularsequences interact either directly or indirectly to carry out theirintended function, such as mediation or modulation of gene expression.The interaction of operatively linked sequences may be mediated byproteins that in turn interact with the sequences, as described herein.A transcriptional regulatory region and a sequence of interest are“operably linked” when the sequences are functionally connected so as topermit transcription of the sequence of interest to be mediated ormodulated by the transcriptional regulatory region.

By the term “expression” it is meant the production of a functional RNA,protein or both, from a gene or transgene.

By “repression of gene expression” it is meant the reduction in thelevel of mRNA, protein, or both mRNA and protein, encoded by a gene ornucleotide sequence of interest. Repression of gene expression may alsoarise as a result of the lack of production of full length RNA, forexample mRNA, due to blocking migration of polymerase along a nucleicacid during transcription. A repression of gene expression may be aconsequence of repressing, blocking or interrupting transcription.

By “repressor” or “repressor protein” it is meant a protein thatexhibits the property of specifically binding to a correspondingoperator sequence. An example of repressor protein, which is not to beconsidered limiting in any manner is the ROS repressor, or an analog orderivative thereof as defined herein. By “ROS repressor” it is meant anyROS repressor as known within the art. These include the ROS repressoras described herein, as well as other microbial ROS repressors, forexample but not limited to ROSAR (Agrobacterium radiobacter; Brightwellet al., (1995) Mol. Plant Microbe Interact. 8: 747-754), MucR (Rhizobiummeliloti; Keller M et al., (1995) Mol. Plant Microbe Interact. 8:267-277), and ROSR (Rhizobium elti; Bittinger et al., (1997) Mol. PlantMicrobe Interact. 10: 180-186; also see Cooley et al. 1991, J.Bacteriol. 173:2608-2616; Chou et al., 1998, Proc. Natl. Acad. Sci., 95:5293; Archdeacon J et al. 2000, FEMS Microbiol Let. 187: 175-178;D'Souza-Ault M. R., 1993, J Bacteriol 175: 3486-3490; all of which areincorporated herein by reference). Examples of a ROS repressor, whichare not to be considered limiting, are provide in FIGS. 1(A) to (C) and(SEQ ID NO's: 1-3 and 21). An analog, or a derivative, of a repressorprotein maybe any protein that exhibits the property of binding anoperator sequence, for example which is not to be considered limiting inany manner, a fusion protein comprising an operator binding sequencefused to a second protein. The second protein may be any protein,including:

-   -   a protein having an activity that regulates gene expression when        bound to the operator sequence, for example but not limited to        histone deacetylase, histone acetyl transferase, yeast Sin3        protein (which recruits Rpd3 (HDA complex) by binding to the DNA        binding protein), Ume6, or transcriptional activators, for        example but nit limited to VP16, Ga14, LexA; or    -   a protein involved in protein-protein interaction, for example        but not limited to chromatin remodelling proteins and HAT/HDA        recruitment factors (Lusser A., Kolle D., Loidl P., 2001, Trends        Plt. Sci. 6: 59-65); or    -   a protein that does not directly interact with transcriptional        processes but when bound to the operator sequence exhibits a        property of blocking interaction of polymerase, or other factors        required for transcription, with the promoter region, or        migration of polymerase along a nucleic acid comprising the        operator sequence, or both, blocks interaction of transcription        factors with the promoter region and blocks polymerase        migration.        Preferably the repressor protein or fusion protein comprises a        nuclear localization signal so that the protein or fusion        protein is directed to the nucleus.

By “codon optimization” it is meant the selection of appropriate DNAnucleotides for the synthesis of oligonucleotide building blocks, andtheir subsequent enzymatic assembly, of a structural gene or fragmentthereof in order to approach codon usage within plants.

By “operator sequence” it is meant a sequence of DNA that can interactor bind with a DNA binding domain of a protein, for example, a repressorprotein. An example of a repressor protein, or a DNA binding domain,that exhibits the property of binding to an operator sequence, and whichis not to be considered limiting, is a ROS repressor, or the DNA bindingdomain of the ROS repressor, respectively. The operator sequence ispreferably located in proximity of a gene of interest, either upstreamof, downstream of, or within, the coding region of a gene, for examplewithin an intron of a gene. When the repressor protein, or the DNAbinding domain of the repressor, binds the operator sequence expressionof the gene in operative association with the operator sequence isreduced. Preferably, the operator sequence is located in the proximityof a regulatory region that is in operative association with a gene ofinterest. However, the operator sequence may also be localized elsewherewithin a first genetic construct to block migration of polymerase alongthe nucleic acid.

An operator sequence may consist of inverted repeat or palindromicsequences of a specified length. The ROS operator may comprise 9 or morenucleotide base pairs (see FIGS. 1(D) and (E)) that exhibits theproperty of binding a DNA binding domain of a ROS repressor. A consensussequence of a 10 base pair region including the 9 base pair DNA bindingsite sequence is WATDHWKMAR (SEQ ID NO: 20; FIG. 1(E)). The lastnucleotide, “R”, of the consensus sequence is not required for ROSbinding (data not presented). Examples of operator sequences, which arenot to be considered limiting in any manner, also include, as is thecase with the ROS operator sequence from the virC or virD genepromoters, a ROS operator made up of two 11 bp inverted repeatsseparated by TTTA: TATATTTCAATTTTATTGTAATATA; (SEQ ID NO:8)

the operator sequence of the IPT gene: TATAATTAAAATATTAACTGTCGCATT. (SEQID NO:19)However, it is to be understood that analogs or variants of SEQ IDNO's:8, 19 and 20 may also be used providing they exhibit the propertyof binding a DNA binding domain, preferably a DNA binding domain of theROS repressor. The ROS repressor has a DNA binding motif of the C₂H₂zinc finger configuration. In the promoter of the divergent VirC/VirDgenes of Agrobacterium tumefaciens, ROS binds to a 9 bp inverted repeatsequence in an orientation-independent manner (Chou et al., 1998, Proc.Natl. Acad. Sci., 95: 5293). The ROS operator sequence in the iptpromoter also consists of a similar sequence to that in the virC/virDexcept that it does not form an inverted repeat (Chou et al., 1998,Proc. Natl. Acad. Sci. USA, 95: 5293). Only the first 9 bp arehomologous to ROS box in virC/virD indicating that the second 9 bpsequence may not be a requisite for ROS binding. Accordingly, the use ofROS operator sequences or variants thereof that retain the ability tointeract with ROS, as operator sequences to selectively control theexpression of genes or nucleoitide sequences of interest, is within thescope of the present invention.

By “regulatory region” or “regulatory element” it is meant a portion ofnucleic acid typically, but not always, upstream of the protein codingregion of a gene, which may be comprised of either DNA or RNA, or bothDNA and RNA. When a regulatory region is active, and, in operativeassociation with a gene of interest, this may result in expression ofthe gene of interest. A regulatory element may be capable of mediatingorgan specificity, or controlling developmental or temporal geneactivation. A “regulatory region” includes promoter elements, corepromoter elements exhibiting a basal promoter activiy, elements that areinducible in response to an external stimulus, elements that mediatepromoter activity such as negative regulatory elements ortranscriptional enhancers. “Regulatory region”, as used herein, alsoincludes elements that are active following transcription, for example,regulatory elements that modulate gene expression such as translationaland transcriptional enhancers, translational and transcriptionalrepressors, upstream activating sequences, and mRNA instabilitydeterminants. Several of these latter elements may be located proximalto the coding region.

In the context of this disclosure, the term “regulatory element” or“regulatory region” typically refers to a sequence of DNA, usually, butnot always, upstream (5′) to the coding sequence of a structural gene,which controls the expression of the coding region by providing therecognition for RNA polymerase and/or other factors required fortranscription to start at a particular site. However, it is to beunderstood that other nucleotide sequences, located within introns, or3′ of the sequence may also contribute to the regulation of expressionof a coding region of interest. An example of a regulatory element thatprovides for the recognition for RNA polymerase or other transcriptionalfactors to ensure initiation at a particular site is a promoter element.Most, but not all, eukaryotic promoter elements contain a TATA box, aconserved nucleic acid sequence comprised of adenosine and thymidinenucleotide base pairs usually situated approximately 25 base pairsupstream of a transcriptional start site. A promoter element comprises abasal promoter element responsible for the initiation of transcription,as well as other regulatory elements (as listed above) that modify geneexpression.

There are several types of regulatory regions, including those that aredevelopmentally regulated, inducible or constitutive. A regulatoryregion that is developmentally regulated, or controls the differentialexpression of a gene under its control, is activated within certainorgans or tissues of an organ at specific times during the developmentof that organ or tissue. However, some regulatory regions that aredevelopmentally regulated may preferentially be active within certainorgans or tissues at specific developmental stages, they may also beactive in a developmentally regulated manner, or at a basal level inother organs or tissues within the plant as well.

An inducible regulatory region is one that is capable of directly orindirectly activating transcription of one or more DNA sequences orgenes in response to an inducer. In the absence of an inducer the DNAsequences or genes will not be transcribed. Typically the proteinfactor, that binds specifically to an inducible regulatory region toactivate transcription, may be present in an inactive form which is thendirectly or indirectly converted to the active form by the inducer.However, the protein factor may also be absent. The inducer can be achemical agent such as a protein, metabolite, growth regulator,herbicide or phenolic compound or a physiological stress imposeddirectly by heat, cold, salt, or toxic elements or indirectly throughthe action of a pathogen or disease agent such as a virus. A plant cellcontaining an inducible regulatory region may be exposed to an inducerby externally applying the inducer to the cell or plant such as byspraying, watering, heating or similar methods. Inducible regulatoryelements may be derived from either plant or non-plant genes (e.g. Gatz,C. and Lenk, I. R. P., 1998, Trends Plant Sci. 3, 352-358; which isincorporated by reference). Examples, of potential inducible promotersinclude, but not limited to, teracycline-inducible promoter (Gatz, C.,1997, Ann. Rev. Plant Physiol. Plant Mol. Biol.48, 89-108; which isincorporated by reference), steroid inducible promoter (Aoyama, T. andChua, N. H., 1997, Plant J. 2,397-404; which is incorporated byreference) and ethanol-inducible promoter (Salter, M. G., et al, 1998,Plant Journal 16, 127-132; Caddick, M. X., et al,1998, Nature Biotech.16, 177-180, which are incorporated by reference) cytokinin inducibleIB6 and CKI1 genes (Brandstatter, I. and Kieber, J. J., 1998, Plant Cell10, 1009-1019; Kakimoto, T., 1996, Science 274, 982-985; which areincorporated by reference) and the auxin inducible element, DR5(Ulmasov, T., et al., 1997, Plant Cell 9, 1963-1971; which isincorporated by reference).

A constitutive regulatory region directs the expression of a genethroughout the various parts of a plant and continuously throughoutplant development. Examples of known constitutive regulatory elementsinclude promoters associated with the CaMV 35S transcript. (Odell etal., 1985, Nature, 313: 810-812), the rice actin 1 (Zhang et al, 1991,Plant Cell, 3: 1155-1165), actin 2 (An et al., 1996, Plant J., 10:107-121), or tms 2 (U.S. Pat. No. 5,428,147, which is incorporatedherein by reference), and triosephosphate isomerase 1 (Xu et. al., 1994,Plant Physiol. 106: 459-467) genes, the maize ubiquitin 1 gene (Cornejoet al, 1993, Plant Mol. Biol. 29: 637-646), the Arabidopsis ubiquitin 1and 6 genes (Holtorf et al, 1995, Plant Mol. Biol. 29: 637-646), and thetobacco translational initiation factor 4A gene (Mandel et al, 1995Plant Mol. Biol. 29: 995-1004). The term “constitutive” as used hereindoes not necessarily indicate that a gene under control of theconstitutive regulatory region is expressed at the same level in allcell types, but that the gene is expressed in a wide range of cell typeseven though variation in abundance is often observed.

The regulatory regions of the first and second nucleotide sequencesdenoted above, may be the same or different. For example, which is notto be considered limiting in any manner, the regulatory elements of thefirst and second genetic constructs may both be constitutive. In thiscase, each of the first aid second nucleotide sequences are maintainedin separate plants, a first and a second plant, respectively. The firstnucleotide sequence encoding a gene of interest is expressed within thefirst plant. The second plant expresses the second nucleic acid sequenceencoding a repressor protein. Crossing of the first and second plantsproduces a progeny that expresses the repressor protein but not the geneof interest. In this manner the expression of gene of interest that isrequired to maintain parent stocks may be retained within a parent plantbut not expressed in a progeny plant. Such a cross may produce sterileoffspring.

Alternatively, which is not to be considered limiting in any manner,either the second regulatory element may be active before, during, orafter, the activity of the first regulatory element, thereby eitherinitially repressing expression of the gene of interest followed bypermitting the expression of the gene of interest or, followingexpression of the gene of interest, the second regulatory elementbecomes active which results in the repression of the expression of thegene of interest. Similarly, the first regulatory element maybe activebefore, during, or after, the activity of the second regulatory element.Other examples, which are not to be considered limiting, include thesecond regulatory element being an inducible regulatory element that isactivated by an external stimulus so that repression of gene expressionmay be controlled through the addition of an inducer. The secondregulatory element may also be active during a specific developmentalstage preceding, during, or following that of the activity of the firstregulatory element. In this way the expression of the gene of interestmaybe repressed or activated as desired within a plant.

The present invention is therefore directed to one or more chimericgenetic constructs comprising a gene of interest operatively linked to aregulatory element where the regulatory element is in operativeassociation with an operator sequence. Any exogenous gene can be used asa gene of interest and manipulated according to the present invention toresult in the regulated expression of the exogenous gene. The presentinvention also pertains to one or more chimeric constructs comprising aregulatory element in operative association with a nucleic acid sequenceencoding a repressor protein.

By “gene of interest”, “nucleotide sequence of interest”, or “codingregion of interest” it is meant any gene, nucleotide sequence, or codingregion that is to be expressed within a host organism. These terms areused interchangeably. Such a nucleotide sequence of interest mayinclude, but is not limited to, a gene or coding region whose producthas an effect on plant growth or yield, for example a plant growthregulator such as an auxin or cytokinin and their analogues, or anucleotide sequence of interest may comprise a herbicide or a pesticideresistance gene, which are well known within the art. A gene or codingregion of interest may encode an enzyme involved in the synthesis of, orin the regulation of the synthesis of, a product of interest, forexample, but not limited to a protein, or an oil product. A nucleotidesequence of interest may encode an industrial enzyme, proteinsupplement, nutraceutical, or a value-added product for feed, food, orboth feed and food use. Examples of such proteins include, but are notlimited to proteases, oxidases, phytases, chitinases, invertases,lipases, cellulases, xylanases, enzymes involved in oil biosynthesisetc.

A nucleotide sequence, or coding region of interest may also include agene that encodes a pharmaceutically active protein, for example growthfactors, growth regulators, antibodies, antigens, their derivativesuseful for immunization or vaccination and the like. Such proteinsinclude, but are not limited to, interleukins, insulin, G-CSF, GM-CSF,hPG-CSF, M-CSF or combinations thereof, interferons, for example,interferon-α, interferon-β, interferon-τ, blood clotting factors, forexample, Factor VIII, Factor IX, or tPA or combinations thereof. If thegene of interest encodes a product that is directly or indirectly toxicto the plant, then by using the method of the present invention, suchtoxicity may be reduced throughout the plant by selectively expressingthe gene of interest within a desired tissue or at a desired stage ofplant development.

A nucleotide sequence, or coding region of interest may also include agene that encodes a protein involved in regulation of transcription, forexample DNA-binding proteins that act as enhancers or basaltranscription factors, histone deacetylases, or histone acetyltransferases. Moreover, a nucleotide sequence of interest may becomprised of a partial sequence or a chimeric sequence of any of theabove genes, in a sense or antisense orientation.

It is also contemplated that a gene, or coding region of interest may beinvolved in the expression of a gene expression cascade, for example butnot limited to a developmental cascade. In this embodiment, the gene ofinterest is preferably associated with a gene that is involved at anearly stage within the gene cascade, for example homeotic genes.Expression of a gene of interest, for example a repressor of homeoticgene expression, represses the expression of a homeotic gene. Expressionof the repressor protein within the same plant, either via crossing,inducuction, temporal or developmental expression of the regulatoryregion, as described herein, de-represses the expression of the homeoticgene thereby initiating a gene cascade. Homeotic genes are well known toone of skill in the art, and include but are hot limited to,transcription factor proteins and associated regulatory regions, forexample controlling sequences that bind AP2 domain containingtranscription factors, for example but not limited to, APETALA2 (aregulator of meristem identity, floral organ specification, seedcoatdevelopment and floral homeotic gene expression; Jofuku et al., 1994),CCAAT box-binding transcription factors (e.g. LEC1; WO 98/37184; Lotan,T., et al.,1998, Cell 93, 1195-1205), or the controlling factorassociated with PICKLE, a gene that produces a thickened, primary rootmeristem (Ogas, J., et al,.1997, Science 277, 91-94).

A gene, or coding region of interest may also be involved in the controlof transgenes across generations, or production ofF1 hybrid plants withseed characteristics that would be undesirable in the parental line orprogeny, for example but not limited to, oil seeds characterized ashaving reduced levels of sinapine biosynthesis within the oil-free meal.In this case, a gene of interest may be any enzyme involved in thesynthesis of one or more intermediates in sinipine biosynthesis. Anexample, which is to be considered non-limiting, is caffeico-methyltransferase (Acc# AAG51676), which is involved in ferulic acidbiosynthesis. Other examples of genes of interest include genes thatencode proteins involved in fiber, or glucosinolate, biosynthesis, or aprotein involved in the biosynthesis of a phytotoxin. Phytotoxins mayalso be used for plant selection purposes. In this non-limiting example,a gene of interest may encode a protein that is capable of metabolizinga compound from a non-toxic form to a toxic form thereby selectivelyremoving plants that express the gene of interest. The phytotoxiccompound may be synthesized from endogenous precursors that aremetabolized by the gene of interest into a toxic form, for example plantgrowth regulators, or the phytotoxic compound may be synthesized from anexogenously applied compound that is only metabolized into:a toxiccompound in the presence of the gene of interest. For example, which isnot to be considered limiting, the gene of interest may comprise indoleacetamide hydrolase (IAH), that converts exogenously applied indoleacetamide (IAM) or naphthaline acetemide (NAM), to indole acetic acid(IAA), or naphthaline acetic acid (NAA), respectively. Over-synthesis ofIAA or NAA is toxic to a plant, however, in the absence of IAH, theapplied IAM or NAM is non-toxic. Similarly, the gene of interest mayencode a protein involved in herbicide resistance, for example, but notlimited to, phosphinothricin acetyl transferase, wherein, in the absenceof the gene-encoding the transferase, application of phosphinothricin,the toxic compound (herbicide) results in plant death. Other genes orcoding regions of interest that encode lethal or conditionally lethalproducts may be found in WO 00/37660 (which is incorporated herein byreference).

The coding region of interest or the nucleotide sequence of interest maybe expressed in suitable plant hosts which are transformed by thenucleotide sequences, or nucleic acid molecules, or genetic constructs,or vectors of the present invention. Examples of suitable hosts include,but are not limited to, agricultural crops including canola, Brassicaspp., maize, tobacco, alfalfa, potato, ginseng, pea, oat, rice, soybean,wheat, barley, sunflower, and cotton. Any member of the Brassica-familycan be transformed with one or more genetic constructs of the presentinvention including, but not limited to, canola, Brassica napus, B.carinata, B. nigra, B. oleracea, B. chinensis, B. cretica, B. incana, B.insularis, B. japonica, B. atlantica, B. bourgeoaui, B. narinosa, B.juncea, B. rapa, Arabidopsis.

The one or more chimeric genetic constructs of the present invention canfurther comprise a 3′ untranslated region. A 3′ untranslated regionrefers to that portion of a gene comprising a DNA segment that containsa polyadenylation signal and any other regulatory signals capable ofeffecting mRNA processing or gene expression. The polyadenylation signalis usually characterized by effecting the addition of polyadenylic acidtracks to the 3′ end of the mRNA precursor. Polyadenylation signals arecommonly recognized by the presence of homology to the canonical form 5′AATAAA-3′ although variations are not uncommon. One or more of thechimeric genetic constructs of the present invention can also includefurther enhancers, either translation or transcription enhancers, asmaybe required. These enhancer regions are well known to persons skilledin the art, and can include the ATG initiation codon and adjacentsequences. The initiation codon must be in phase with the reading frameof the coding sequence to ensure translation of the entire sequence.

Examples of suitable 3′ regions are the 3′ transcribed non-translatedregions containing a polyadenylation signal of Agrobacterium tumorinducing (Ti) plasmid genes, such as the nopaline synthase (Nos gene)and plant genes such as the soybean storage protein genes and the smallsubunit of the ribulose-1,5-bisphosphate carboxylase (ssRUBISCO) gene.

To aid in identification of transformed plant cells, the constructs ofthis invention may be further manipulated to include plant selectablemarkers. Useful selectable markers include enzymes which provide forresistance to chemicals such as an antibiotic for example, gentamycin,hygromycin, kanamycin, or herbicides such as phosphinothrycin,glyphosate, chlorosulfuron, and the like. Similarly, enzymes providingfor production of a compound identifiable by colour change such as GUS(β-glucuronidase), or luminescence, such as luciferase or GFP, areuseful.

Also considered part of this invention are transgenic plants containingthe chimeric gene construct of the present invention. However, it is tobe understood that the chimeric gene constructs of the present inventionmay also be combined with gene of interest for expression within a rangeof plant hosts.

Methods of regenerating whole plants from plant cells are also known inthe art. In general, transformed plant cells are cultured in anappropriate medium, which may contain selective agents such asantibiotics, where selectable markers are used to facilitateidentification of transformed plant cells. Once callus forms, shootformation can be encouraged by employing the appropriate plant hormonesin accordance with known methods and the shoots transferred to rootingmedium for regeneration of plants. The plants may then be used toestablish repetitive generations, either from seeds or using vegetativepropagation techniques. Transgenic plants can also be generated withoutusing tissue cultures (for example, Clough and Bent, 1998)

The constructs of the present invention can be introduced into plantcells using Ti plasmids, Ri plasmids, plant virus vectors, direct DNAtransformation, micro-injection, electroporation, etc. For reviews ofsuch techniques see for example Weissbach and Weissbach, Methods forPlant Molecular Biology, Academy Press, New York VIII, pp. 421-463(1988); Geierson and Corey, Plant Molecular Biology, 2d Ed. (1988); andMiki and Iyer, Fundamentals of Gene Transfer in Plants. In PlantMetabolism, 2d Ed. D T. Dennis, D H Turpin, D D Lefebrve, D B Layzell(eds), Addison Wesly, Langmans Ltd. London, pp. 561-579 (1997); Cloughand Bent (1998)). The present invention further includes a suitablevector comprising the chimeric gene construct.

An “analogue” or “derivative” includes any substitution, deletion, oraddition to the nucleotide or amino acid sequence of the repressorprotein, for example but not limited to, the ROS repressor, providedthat the analogue or derivative thereof, maintains the property ofbinding or associating with the operator sequence, ROS repressoractivity, or both. Preferably, the repressor protein, or an analogue orderivative thereof exhibits the property of binding an operatorsequence, and exhibits the property of repressing the expression of agene in operative association with the operator sequence.

The DNA sequences of the present invention include the DNA sequences ofSEQ ID NO: 1, 2 and 3 (native or wild-type ROS repressor, synthetic ROSrepressor, and a composite or consensus ROS repressor; also see FIGS.1(B) and-(C)) derivatives, and fragments thereof, as well as analoguesof, or nucleic acid sequences that are substantially homologous to, andthat exhibit greater than 80% similarity with, the nucleic acid sequenceas defined in SEQ ID NO: 2 or 3. If a fragment of a ROS repressor isused, the fragment is at least of about 54 nucleotides in length inorder to cover the zinc finger domain (from 249 to 303). Preferably, thefragment is from about 54 to about 150 nucleotides in length, morepreferably from about 54 to about 80 nucleotides in length.

Sequences that exhibit greater than 80% similarity, maybe determined byuse of the BLAST algorithm (GenBank:www.ncbi.nlm.nih.gov/cgi-bin/BLAST/), using default parameters (Program:blastn; Database: nr; Expect 10; filter: low complexity; Alignment:pairwise; Word size:11). Analogs, or derivatives thereof, also includethose DNA sequences which hybridize under stringent hybridizationconditions (see Maniatis et al., in Molecular Cloning (A Laboratorymanual), Cold Spring Harbor Laboratory, 1982, p. 387-389) to any one ofthe DNA sequences of SEQ ID NO: 1, 2 or 3 provided that the sequencesexhibit the property of binding an operator sequence (operator bindingactivity); or maintain the property of repressing the expression of agene in operative association with the operator sequence. An example ofone such stringent hybridization conditions may be hybridization with asuitable probe, for example but not limited to, a [α-³²P]dATP labelledprobe for 16-20 hrs at 65° C. in 7% SDS, 1 mM EDTA, 0.5M Na₂HPO₄, pH7.2. Followed by washing in 5% SDS, 1 mM EDTA 40 mM Na₂HPO₄, pH 7.2 for30 min followed by washing in 1% SDS, 1 mM EDTA 40 mM Na₂HPO₄, pH 7.2for 30 min. Washing in this buffer may be repeated to reduce background.An example of an analog or a derivative of the ROS repressor, which isnot to be considered limiting in any manner, includes the ROS operatorbinding sequence fused to a second protein to produce a fusion protein,providing that the fusion protein exhibits ROS operator sequence bindingactivity.

The second protein that is fused to the DNA binding sequence, may be anyprotein, including a protein having an activity that regulates geneexpression when bound to the operator sequence, for example but notlimited to histone deacetylase, histone acetyl transferase, a proteininvolved in protein-protein interaction, or a protein that does notdirectly interact with transcriptional processes, but that exhibits acharacteristic of steric hindrance, for example, interfering with theassociation of polymerase or other transcription factor within thepromoter region, or by blocking migration of polymerase along a nucleicacid.

The present invention is further directed to one or more nucleotideconstructs comprising a nucleotide sequence (coding region) of interestoperatively linked to a regulatory region that is modified to containone or more operator sequences, for example, but not limited to, one ormore ROS operator sequences (see FIGS. 3, 4, or 5). As shown in FIG. 3an operator sequence may be placed downstream (FIG. 3(A)), upstream(FIG. 3(B)), or upstream and downstream (FIG. 3(C)) of the TATA boxwithin a regulatory region. The operator sequences may be placed withina promoter region as single binding elements or as tandem repeats (seeFIG. 5(B)). Furthermore, as shown in FIG. 4(B)), tandem repeats of anoperator sequence can be placed downstream of the entire promoter orregulatory region and upstream of the gene or nucleotide sequence ofinterest. An operator sequence, or repeats of an operator sequence mayalso be positioned within untranslated or translated leader sequences(if positioned in-frame), introns of a gene, or within an ORF of a gene,if inserted in-frame. Any gene or nucleotide sequence may be used as thegene or nucleotide sequence of interest and be selectively targeted forregulation of gene expression according to the present invention.

The repressor protein that is produced from the second nucleotidesequence, for example but not limited to a ROS repressor, can bind tooperator sequences contained within the regulatory region of the firstnucleotide sequence and thereby specifically and selectively represstranscription of the gene of interest. Preferably, the first nucleotidesequence and the second nucleotide sequence are chromosomally integratedinto a plant or plant cell. The two nucleotide sequences may beintegrated into two different genetic loci of a plant or plant cell, orthe two nucleotide sequences may be integrated into a singular geneticlocus of a plant or plant cell.

The ROS transcription factor (ROS repressor, FIG. 1(A); SEQ ID NO:3),for example, of Agrobacterium tumefaciens (SEQ ID NO's:1 and 21, nucleicacid and amino acid sequence, respectively) has a DNA binding motif (seebolded amino acids, FIG. 1(C)) of the C₂H₂ zinc finger configuration(Chou et al., 1998, Proc. Natl. Acad. Sci., 95: 5293). Zinc finger DNAbinding proteins represent a significant portion of transcriptionfactors in eukaryotes, but are rare in prokaryotes. The zinc finger ROSprotein varies from its counterparts in eukaryotes in two aspects:

-   -   1. Unlike most eukaryotic zinc finger proteins, which contain        multiple zinc finger motifs, the ROS repressor has only one such        motif.    -   2. There are 9 amino acid residues making up the peptide loop        spacing the zinc finger motif in the ROS repressor as compared        to the 12 amino acids that make up the loops of zinc fingers of        eukaryotic proteins.        These two characteristics of the ROS zinc finger motif, and        possibly, the small size of the ROS repressor (˜15.5 kDa)        provide structural uniqueness and molecular flexibility and that        make the ROS repressor, or analogs thereof, a suitable candidate        as a transcription factor for regulation of gene expression in        plants. However, it is to be understood that larger size        chimeric proteins comprising a ROS operator binding domain may        also be used as described herein.

The ROS repressor is encoded by a nucleotide sequence of bacterialorigin and, as such the nucleotide sequence may be optimised, forexample, by changing its codons to favour plant codon usage (e.g. SEQID) NO:2), by attaching a nucleotide sequence encoding a nuclearlocalisation signal, for example but not limited to SV40 localizationsignal (see Robbins et al., 1991, Cell, 64: 615-623; Rizzo, P., DiResta, I., Powers, A., Ratner, H. and Carbone, M. 1991, Cancer Res. 59(24), 6103-6108; which are incorporated herein by reference) in order toimprove the efficiency of ROS transport to the plant nucleus tofacilitate the interaction with its respective operator, or bothoptimizing plant codon usage and fusing a nuclear localization signal tothe ROS repressor nucleic acid sequence. Other possible nuclearlocalization signals that may be used include but are not limited tothose listed in Table 1: TABLE 1 nuclear localization signals NuclearProtein Organism NLS Ref AGAMOUS A RienttnrqvtfcKRR 1 (SEQ ID NO: 31)TGA-1A T RRlaqnreaaRKsRlRKK 2 (SEQ ID NO: 32) TGA-1B TKKRaRlvrnresaqlsRqRKK 2 (SEQ ID NO: 33) O2 NLS B M RKRKesnresaRRsRyRK 3(SEQ ID NO: 34) NIa V KKnqkhklkm-32aa-KRK 4 (SEQ ID NO: 35)Nucleoplasmin X KRpaatkkagqaKKKKl 5 (SEQ ID NO: 36) NO38 XKRiapdsaskvpRKKtR 5 (SEQ ID NO: 37) N1/N2 X KRKteeesplKdKdaKK 5 (SEQ IDNO: 38) Glucocorticoid receptor M, R RKclqagmnleaRKtKK 5 (SEQ ID NO: 39)α receptor H RKclqagmnleaRKtKK 5 (SEQ ID NO: 40) β receptor HRKclqagmnleaRKtKK 5 (SEQ ID NO: 41) Progesterone receptor C, H, RaRKccqagmvlggRKfKK 5 (SEQ ID NO: 42) Androgen receptor HRKcyeagmtlgaRKlKK 5 (SEQ ID NO: 43) p53 C RRcfevrvcacpgRdRK 5 (SEQ IDNO: 44)⁺A, Arabidopsis; X, Xenopus; M, mouse; R, rat; Ra, rabbit; H, human; C,chicken; T, tobacco; M, maize; V, potyvirus.References:1, Yanovsky et al., 1990, Nature, 346: 35-392, van der Krol and Chua, 1991, Plant Cell, 3: 667-6753, Varagona et al., 1992, Plant Cell, 4: 1213-12274, Carrington et al., 1991, Plant Cell, 3: 953-9625, Robbins et al., 1991, Cell, 64: 615-623

The fusion of a nuclear localization signal to the repressor protein orfusion protein facilitates migration of the repressor, or fusion,protein into the nucleus. Without wishing to be bound by theory, reducedlevels of repressor or fusion proteins elsewhere within the cell may beimportant when the repressor or fusion protein may bind analogueoperator sequences within other organelles, for example within themitochondrion or chloroplast. Furthermore, the use of a nuclearlocalization signal may permit the use of a less active promoter orregulatory region to drive the expression of the repressor, or fusion,protein while ensuring that the concentration of the expressed proteinremains at a desired level within the nucleus, and that theconcentration of the protein is reduced elsewhere in the cell.

The nuclear localization signal may be fused to the N, C, or both the Nand C terminus of the ROS protein. Furthermore, the nuclear localizationsignal may be fused within the coding region of the gene, provided thatthe activity of the protien is retained. Preferably, the nuclearlocalization signal is fused to the carboxy-terminus of the protein orfusion protien. The nucleotide sequence, depicted in FIG. 1(B) or SEQ IDNO:2, consisting of the fusion of the modified nucleotide sequence ofthe protein coding region of ROS with the nucleotide sequence encodingthe nuclear localization signal is designated as “synthetic ROS”. Thus,analogues of the nucleotide sequence encoding ROS repressor, or theamino acid sequence of the ROS repressor, are within the scope of thepresent invention.

In order to optimize expression levels and transgene protein productionof a repressor protein, for example the ROS repressor, the nucleic acidsequence of the ROS repressor was examined and the coding regionmodified to optimize for expression of the gene in plants. A proceduresimilar to that outlined by Sardana et al. (Plant Cell Reports15:677-681; 1996) may also be used. A table of codon usage from highlyexpressed genes of dicotyledonous plants was compiled using the data ofMurray et al. (Nuc Acids Res. 17:477-498; 1989). An example of asynthetic ROS repressor gene comprising codons optimized for expressionwithin plants is shown in FIG. 1(B). However, it is to be understoodthat other base pair combinations may be used for the preparation of asynthetic ROS repressor gene, for example SEQ ID NO:3, using the methodsas described herein in order to optimize ROS repressor expression withina plant.

Assembly of the synthetic ROS repressor gene of this invention isperformed using standard technology know in the art. The gene may beassembled enzymatically, within a DNA vector, for example, using PCR, orsynthesised from chemically synthesized oligonucleotide duplex segments.The synthetic gene is then introduced into a plant using methods knownin the art. Expression of the gene maybe determined using methods knownwithin the art, for example Northern analysis, Western analysis, orELISA.

The present invention also pertains to the regulation of gene expressionin plants using the ROS repressor protein, whereby the ROS repressor isused as a regulatory switch to repress the expression of selected codingregions or nucleotide sequences of interest. The repression of theexpression of a gene of interest may be accomplished by transforming theplant with two constructs:

1. A first genetic construct comprising a gene or nucleotide sequence ofinterest operatively associated with a regulatory region containing atleast one operator sequence that can interact with the ROS repressor.

2. A second genetic construct comprising an appropriate regulatoryregion operatively linked to a nucleotide sequence that encodes the ROSrepressor.

The first and second genetic constructs may be inserted into a plant inseparate vectors, each of which maybe introduced into a plant viaco-transformation sequentially, or at the same time, or introduced intoa plant by crossing plants expressing either the first or second geneticconstruct, or both genetic constructs may reside within one vector, andbe introduced within a plant at the same time.

Preferably, the protein coding region of the nucleotide sequenceencoding the ROS repressor is modified to favour plant codon usage.Furthermore, it is preferred that the nucleotide sequence is operativelylinked with a nucleotide sequence encoding a nuclear localisationsignal. Expression of both constructs within the same plant will resultin a repression of the expression of the gene of interest as mediated byan interaction of the ROS repressor with a ROS operator sequencecontained within the regulatory region of the first genetic construct.

Schematic representations of constructs capable of expressing syntheticROS or wild type ROS are shown in FIG. 2(A; wild type ROS) and FIGS.2(B)-(D; synthetic ROS). Southern analysis (FIG. 6(B)) of Arabidopsisplants that are transformed with constructs comprising the secondnucleic acid sequence of the present invention, expressing ROS repressorprotein, indicates that both the wild type ROS and the synthetic ROS areintegrated into the chromosome of Arabidopsis. Western blots shown inFIG. 7 demonstrate that both native ROS and synthetic ROS may beexpressed within plants.

Similarly, stable integration and expression of the first nucleotidesequence of the present invention comprising a gene of interest, inoperative association with a regulatory region which is in operativeassociation with an operator sequence is seen in FIG. 6(A) (Southernanalysis) and FIG. 8 (GUS expression).

Crossing plants expressing the first nucleotide sequence, comprising agene or coding region of interest, for example but not limited to GUS,and the second nucleotide sequence encoding ROS repressor, either nativeor synthetic ROS, exhibit reduced expression of the coding region ofinterest, in this case GUS. Results of a cross between a transgenic lineexpressing synthetic ROS (ROS parent) and a nucleotide sequence ofinterest, for example, but not limited to GUS (GUS parent), arepresented in FIG. 9 and demonstrate ROS mediated repression of a gene ofinterest.

As shown in FIG. 9A, GUS activity is detected in the GUS parent(expressing p74-118; see FIG. 5C for construct) but not in the ROSparent (p74-101; see FIG. 2D for construct), or in the progeny of thecross between the ROS and GUS parents (cross between plant linesexpressing p74-101 and p74-118). The parent plants each expressed eitherGUS or ROS RNA as expected (FIG. 9B), yet no GUS RNA was detected in theprogeny arising from a cross between the ROS and GUS parents. Southernanalysis of the progeny of the cross between the GUS and ROS parentsindicates that the progeny plant from the cross between the ROS and GUSparent comprised genes encoding both GUS and ROS (FIG. 9C).

Similar results of the inhibition of expression of a coding region ofinterest from about 20 to about 95% inhibition (of the expressionobserved in the parental lines), is also observed in a variety ofcrosses made between platform plants expressing a first nucleotidesequence comprising a regulatory region with one, or more than oneoperator sequences operatively linked with a coding region of interest(e.g. reporter construct; see FIG. 10B for non-limiting examples ofconstructs) and plants expressing a repressor (see FIG. 10A fornon-limiting examples of constructs) as shown in FIG. 11A (GUSexpression) and FIG. 11B (ROS expression; see Table 5 of the Examples,or the figure legend to FIG. 11, for a description of the crosses), FIG.11D shows quantification of the data of FIG. 11A (using a GUS probe). Asan example, progeny of a cross, C2, between a plant line comprising afirst nucleotide sequence, p74-316 (35S-1x OS-GUS), and a plant linecomprising a second nucleotide sequence, p74-101 (Actin2-synRos)resulted in reduced expression of GUS (FIG. 11A, lanes C2 A-G) comparedto GUS expression in the parent plants, P2 GUS or P2 ROS. Quantificationof GUS RNA for this cross is provided in FIG. 11D (lanes C2A-G, and P2GUS.

FIG. 13 provides further evidence for inhibition of expression of acoding region of interest by a repressor protein (as compared toexpression of the coding region of interest in a parental cell line thatdoes not produce a repressor) where the coding region of interest isoperatively linked to a regulatory region that is able to be controlledby one, or more than one operator sequences that can bind or interactwith the repressor. FIG. 12A shows the structure of a repressorconstruct (a non-limiting example of a second genetic construct of theinvention) in which an actin2 regulatory region is operatively linked toa protein coding region of synthetic ROS. FIG. 121 shows the structureof a construct encoding a GUS reporter (a non-limiting example of afirst genetic construct of-the invention) in which a CaMV35S regulatoryregion, modified to contain 4 ROS operator sequences, is operativelylinked to a coding region of interest encoding GUS. Parental linesseparately comprising a first nucleotide sequence comprising a codingregion of interest (for example, a GUS reporter) and a second nucleotidesequence comprising a region coding for a repressor (for example, a ROSrepressor) are crossed to produce plants comprising both first andsecond nucleotide sequences and the expression of the coding region ofinterest can be analyzed by any standard method. As shown in FIG. 13Blevels of expression of a GUS reporter gene in crosses and parentallines is analyzed by Northern blot with densitometry analysis of theNorthern blot shown in FIG. 13C.

These data further demonstrates that progeny of a cross between a plantexpressing a first nucleotide sequence (comprising a coding region ofinterest) and a plant expressing a second nucleotide sequence(comprising a repressor) exhibit reduced levels of expression, of fromabout 20% to about 95%, of a coding region of interest.

These data demonstrate that expression of a gene of interest can becontrolled using the repressor mediated system as described herein.

Examples of suitable hosts include, but are not limited to, agriculturalcrops including canola, Brassica spp., maize, tobacco, alfalfa, potato,ginseng, pea, oat, rice, soybean, wheat, barley, sunflower, and cotton.Any member of the Brassica-family can be transformed with one or moregenetic constructs of the present invention including, but not limitedto, Arabidopsis, Brassica amplexicaulis, Brassica atlantica, Brassicabalearica, Brassica barrelieri, Brassica bourgeaui, Brassica carinata(Abyssinian mustard), Brassica chinensis, Brassica cretica, Brassicadeflexa, Brassica erucastrum, Brassica hilarionis, Brassica incana,Brassica insularis, Brassica insularis subsp. insularis, Brassica juncea(Indian mustard), Brassica macrocarpa, Brassica maurorum, Brassicamontana, Brassica napus (rape), Brassica napus var. napobrassica(Swedish turnip), Brassica napus var. napus (canola), Brassica narinosa,Brassica nigra (black mustard), Brassica oleracea, Brassica oleraceavar. acephala (kale), Brassica oleracea var. alboglabra (Chinese kale),Brassica oleracea var. botrytis (cauliflower), Brassica oleracea var.capitata (cabbage), Brassica oleracea var. gemmifera (brussel sprouts),Brassica oleracea var. gongylodes (kohlrabi), Brassica oleracea var.italica (asparagus broccoli), Brassica oleracea var. medullosa(marrow-stem kale), Brassica oleracea var. oleracea, Brassica oleraceavar. ramosa (branching bush kale), Brassica oxyrrhina, Brassica rapa(field mustard), Brassica rapa subsp. chinensis (bok-choy), Brassicarapa subsp. oleifera (biennial turnip rape), Brassica rapa subsp.pekinensis (Chinese cabbage), Brassica rapa subsp. rapa (turnip),Brassica rupestris, Brassica tournefortii, Brassica villosa.

The above description is not intended to limit the claimed invention inany manner, furthermore, the discussed combination of features might notbe absolutely necessary for the inventive solution.

The present invention will be further illustrated in the followingexamples. However it is to be understood that these examples are forillustrative purposes only, and should not be used to limit the scope ofthe present invention in any manner.

EXAMPLES Materials and Methods

Plant Material

Wild type Arabidopsis thaliana, ecotype Columbia, seeds were germinatedon Redith (W.R. Grace & Co., Ajax, On) soil in pots covered with windowscreens under green house conditions (˜25° C., 16 hr light). Emergingbolts were cut back to encourage further bolting. Plants were used fortransformation once multiple secondary bolts had been generated.

Plant Transformation

Plant transformation was carried out according to the floral dipprocedure described in Clough and Bent (1998, Plant J., 16, 735).Essentially, Agrobacterium tumefaciens transformed with the construct ofinterest (using standard methods as known in the art) was grownovernight in a 100 ml Luria-Bertani Broth (10 g/L NaCl, 10 g/L tryptone,5 g/L yeast extract) containing 50 ug/ml kanamycin. The cell suspensionculture was centrifuged at 3000× g for 15 min. The pellet wasresuspended in 1L of the transformation buffer (sucrose (5%), Silwet L77(0.05%)(Loveland Industries, Greeley, Colo.)). The above-ground parts ofthe Arabidopsis plants were dipped into the Agrobacterium suspension for˜1 min and the plants were then transferred to the greenhouse. Theentire transformation process was repeated twice more at two dayintervals. Plants were grown to maturity and seeds collected. To selectfor transformants, seeds were surface sterilized by washing in 0.05%Tween 20 for 5 minutes, with 95% ethanol for 5 min, and then with asolution containing sodium hypochlorite (1.575%) and Tween 20 (0.05%)for 10 min followed by 5 washings in sterile water. Sterile seeds wereplated onto either Pete Lite medium (20-20-20 Peter's Professional PeteLite fertilizer (Scott, Marysville, Ohio) (0.762 g/l), agar (0.7%),kanamycin (50 ug/ml), pH 5.5) or MS medium (MS salts (0.5×)(Sigma), B5vitamins (1×), agar (0.7%), kanamycin (50 ug/ml) pH 5.7). Plates wereincubated at 20° C., 16 hr light/8 hr dark in a growth room. Afterapproximately two weeks, seedlings possessing green primary leaves weretransferred to soil for further screening and analysis.

Example 1

Optimization of ROS Protein Coding Region.

The ros nucleotide sequence is derived from Agrobacterium tumefaciens(SEQ ID NO:1; FIG. 1A). Analysis of the protein coding region of the rosnucleotide sequence indicates that the codon usage may be altered tobetter conform to plant translational machinery. The protein codingregion of the ros nucleotide sequence was therefore modified to optimizeexpression in plants (SEQ ID NO:2; FIG. 1B). The nucleic acid sequenceof the ROS repressor was examined and the coding region modified tooptimize for expression of the gene in plants, using a procedure similarto that outlined by Sardana et al. (Plant Cell Reports 15:677-681;1996). A table of codon usage from highly expressed genes ofdicotyledonous plants was compiled using the data of Murray et al. NucAcids Res. 17:477-498; 1989). The ros nucleotide sequence was alsomodified (SEQ ID NO:2; FIG. 1B) to ensure localization of the ROSrepressor to the nucleus of plant cells, by adding a SV40 nuclearlocalization signal (Rizzo, P., Di Resta, I., Powers, A., Ratner, H. andCarbone, M. Cancer Res. 59 (24), 6103-6108 (1999; The nuclearlocalization signal resides at amino acid positions 126-132; accessionnumber AAF28270).

The ros gene is cloned from Agrobacterium tumefaciens by PCR. Thenucleotide sequence encoding the ROS protein is expressed in, andpurified from, E. coli, and the ROS protein used to generate an anti-ROSantiserum in rabbits using standard methods (Maniatis et al.).

Example 2

Constructs that Express Synthetic ROS Repressor, or Wild Type ROSRepressor and Preparation of Repressor Lines.

The protein coding region of the ros gene is modified to favourArabidopsis thaliana and Brassica napus codon usage, and in someconstructs, to incorporate a nucleotide sequence encoding a nuclearlocalization signal at its carboxy terminus as described below. Amodified ros nucleotide sequence comprising optimized codons and thenuclear localization signal is referred to as “synthetic ROS”. In thisexample, the ROS coding portion of the synthetic ROS nucleotide sequenceis designed to encode the same protein as the wild type bacterial rosnucleotide sequence, while optimizing codon usage in plants or plantcells.

p74-107: Construct for The Expression of The Wild Type ROS Driven by TheCaMV 35S Promoter (FIG. 2(A)).

The protein coding region of the wild type ROS gene is amplified by PCRusing total genomic DNA of Agrobacterium tumefaciens 33970 and thefollowing two primers with built-in BamHI (G GAT CC) and HindIII (A AGCTT) sites: Sense primer: (SEQ ID NO:4) 5-GCG GAT CCG ATG ACG GAA ACT GCATAC-3′ Anti-sense primer: (SEQ ID NO:5) 5′-GCA AGC TTC AAC GGT TCG CCTTGC G-3′.

The PCR product, which lacks any nuclear localization signal, is clonedinto the BamHI/HindIII sites of the pGEX vector (Pharmacia), excisedfrom pGEX as a XhoI/BamHI fragment, and the Xho I site blunt-ended usingKlenow. The resulting fragment is cloned into the BamHI/EcoICR1 sites ofpBI121 (Clontech, Palo Alto, Calif.).

p74-313: Construct for The Expression of The Synthetic ROS Driven by TheCaMV 35S Promoter (FIG. 2(B)).

The ORF of the ROS repressor is re-synthesized to favor plant codonusage as outlined above, and to incorporate a SV40 nuclear localizationsignal, PKKKRKV, at its carboxy terminus. The re-synthesized ROS iscloned into the BamHI-SacI sites of pUC19, and subcloned into pBI121 asa BamHI/SstI fragment replacing the GUS ORF in this vector.

p74-108: Construct for The Expression of The Synthetic ROS RepressorDriven by the tms2 Promoter (FIG. 2(C)).

The tms2 promoter is PCR amplified from genomic DNA of Agrobacteriumtumefaciens 33970 using the following two primers: sense primer: 5′-TGCGGA TGC ATA AGC TTG CTG ACA (SEQ ID NO:6) TTG CTA GAA AAG-3′ anti-senseprimer: 5′-CGG GGA TCC TTT CAG GGC CAT TTC (SEQ ID NO:7) AG-3′

The 352 bp PCR fragment is cloned into the EcoRV site of pBluescript,and excised from pBluescript as a HindIII/BamHI fragment, and sub-clonedinto the HindIII/BamHI sites of p74-313, see below, replacing the CaMV35S promoter.

p74-101: Construct for The Expression of The Synthetic ROS Driven by TheActin2 Promoter (FIG. 2(D)).

The Actin2 promoter (An et al., 1996, Plant J., 10: 107-121) is PCRamplified from genomic DNA of Arabidopsis thaliana ecotype Columbia asdescribed in 74-501 (see below) and cloned into pGEM-T-Easy. The 1.2 kbpHindIII/SpeI fragment of the Actin2 promoter is then cloned into p74-313(see below) as a HindIII/XbaI fragment replacing the CaMV 35S promoter.

The various constructs are introduced into Arabidopsis, as describedabove, and transgenic plants are generated. Transformed plants areverified using PCR or Southern analysis. FIG. 6(B) show Southernanalysis of transgenic plants comprising a second genetic construct, forexample, p74-101 (actin2-synthetic ROS; FIG. 2(D)).

Western Blot Analysis of Repressor Transgenic Lines

The expression of ROS in the repressor lines is assessed by Western blotanalysis using a ROS polyclonal antibody. Several lines show high levelsof ROS expression. These included plants expressing both the wild typeROS (without any nuclear localization signal) as well as thoseexpressing the synthetic ROS nucleic acid sequences.

Total plant protein extracts are analyzed for the expression of the ROSprotein using a polyclonal rabbit anti-ROS antibody. Chemiluminescentdetection of antigen-antibody complexes is carried out with goatanti-rabbit IgG secondary antibody conjugated to horseradishporoxidase-conjugated (from Bio-Rad Laboratories) in conjunction withECL detection reagent (from Ameisham Pharamcia Biotech).

Levels of ROS protein, both wild type ROS (WTROS), for example p74-107(35S-WTROS; FIG. 2(A)), and synthetic ROS, for example p74-101(actin2-synROS; FIG. 2(D)), produced in the trangenic plants isdetermined by Western blot analysis using a ROS polyclonal antibody(FIG. 7).

Representative lines showing various levels of expression were used as asource of pollen for pollination of reporter lines containing singleinserts.

Example 3

Constructs Placing a Gene of Interest Under Transcriptional Control ofRegulatory Regions that have been Modified to Contain ROS OperatorSites, and Preparation of Reporter Lines.

p74-315: Construct for The Expression of GUS Gene Driven by a CaMV 35SPromoter Containing a ROS Operator Downstream of TATA Box (FIG. 3(A)).

The BamHI-EcoRV fragment of CAMV 35S promoter in pBI121 is cut out andreplaced with a similar synthesized DNA fragment in which the 25 bpimmediately downstream of the TATA box were replaced with the ROSoperator sequence: TATATTTCAATTTATTGTAATATA. (SEQ ID NO:8)

Two complementary oligos, ROS-OPDS (SEQ ID NO:9) and ROS-OPDA (SEQ IDNO:10), with built-in BamHI-EcoRV ends, and spanning the BamHI-EcoRVregion of CaMV35S, in which the 25 bp immediately downstream of the TATAbox are replaced with the ROS operator sequence (SEQ ID NO:8), areannealed together and then ligated into the BamHI-EcoRV sites ofCaMV35S. ROS-OPDS: 5′-ATC TCC ACT GAC GTA AGG GAT GAC (SEQ ID NO:9) GCACAA TCC CAC TAT CCT TCG CAA GAC CCT TCC TCT ATA TAA TAT ATT TCA ATT TTATTG TAA TAT AAC ACG GGG GAC TCT AGA G-3′ ROS-OPDA: 5′-G ATC CTC TAG AGTCCC CCG TGT (SEQ ID NO:10) TAT ATT ACA ATA AAA TTG AAA TAT ATT ATA TAGAGG AAG GGT CTT GCG AAG GAT AGT GGG ATT GTG CGT CAT CCC TTA CGT CAG TGGAGA T-3′

The p74-315 sequence from the EcoRV site (GAT ATC) to the first codon(ATG) of GUS is shown below (TATA box—lower case in bold; the syntheticROS sequence—bold caps; a transcription start site—ACA, bold italics;BamHI site—GGA TCC; and the first of GUS, ATG, in italics; are alsoindicated): 5′-GAT ATC TCC ACT GAC GTA AGG GAT (SEQ ID NO:22) GAC GCACAA TCC CAC TAT CCT TCG CAA GAC CCT TCC TCt ata taA TAT ATT TCA ATT TTATTG TAA TAT A

    CG GGG GAC TCT AGA GGA TCC CCG GGT GGT CAG TCC CTT ATG-3′p74-316: Construct for The Expression of GUS Driven by a CaMV 35SPromoter Containing a ROS Operator Upstream of TATABox (FIG. 3(B)).

TheBamHI-EcoRV fragment of CaMV 35S promoter in pBI121 is cut out andreplaced with a similar synthesized DNA fragment in which the 25 bpimmediately upstream of the TATA box are replaced with the ROS operatorsequence (SEQ ID NO:8). Two complementary oligos, ROS-OPUS (SEQ IDNO:11) and ROS-OPUA (SEQ ID NO:12), with built-in BamHI-EcoRV ends, andspanning the BamHI-EcoRV region of CaMV35S, in which the 25 bpimmediately upstream of the TATA box were replaced with a ROS operatorsequence (SEQ ID NO:8), are annealed together and then ligated into theBamHI-EcoRV sites of CaMV35S. ROS-OPUS: 5′-ATC TCC ACT GAC GTA AGG GATGAC (SEQ ID NO:11) GCA CAA TCT ATA TTT CAA TTT TAT TGT AAT ATA CTA TATAAG GAA GTT CAT TTC ATT TGG AGA GAA CAC GGG GGA CTC TAG AG-3′ ROS-OPUA:5′-G ATC CTC TAG AGT CCC CCG TGT (SEQ ID NO:12) TCT CTC CAA ATG AAA TGAACT TCC TTA TAT AGT ATA TTA CAA TAA AAT TGA AAT ATA GAT TGT GCG TCA TCCCTT ACG TCA GTG GAG AT-3′

The p74-316 sequence from the EcoRV site (GAT ATC) to the first codon(ATG) of GUS is shown below (TATA box—lower case in bold; the syntheticROS sequence—bold caps; a transcription start site—ACA, bold italics;BamHI site—GGA TCC; the first codon of GUS, ATG-italics, are alsoindicated): 5′-GAT ATC TCC ACT GAC GTA AGG GAT (SEQ ID NO:23) GAC GCACAA TCT ATA TTT CAA TTT TAT TGT AAT ATA Cta tat aAG GAA GTT CAT TTC ATTTGG AGA GA

    C GGG GGA CTC TAG AGG ATC CCC GGG TGG TCA GTC CCT TAT G-3′p74-309: Construct for The Expression of GUS Driven by a CaMV 35SPromoter Containing ROS Operators Upstream and Downstream of TATA Box(FIG. 3(C)).

The BamHI-EcoRV fragment of CaMV 35S promoter in pBI121 is cut out andreplaced with a similar synthesized DNA fragment in which the 25 bpimmediately upstream and downstream of the TATA box were replaced withtwo ROS operator sequences (SEQ ID NO:8). Two complementary oligos,ROS-OPPS (SEQ ID NO: 13) and ROSOPPA (SEQ ID NO:14), with built-inBamHI-EcoRV ends, and spanning the BamHI-EcoRV region of CaMV35S, inwhich the 25 bp immediately upstream and downstream of the TATA box arereplaced with two ROS operator sequences, each comprising the sequenceof SEQ ID NO:8 (in italics, below), are annealed together and ligatedinto the BamHI-EcoRV sites of CaMV35S. ROS-OPPS: 5′-ATC TCC ACT GAC GTAAGG GAT GAC (SEQ ID NO:13) GCA CAA TCT ATA TTT CAA TTT TAT TGT AAT ATACTA TAT AAT ATA TTT CAA TTT TAT TGT AAT ATA ACA CGG GGG ACT CTA GAG-3′ROS-OPPA: 5′-G ATC CTC TAG AGT CCC CCG TGT (SEQ ID NO:14) TAT ATT ACAATA AAA TTG AAA TAT ATT ATA TAG TAT ATT ACA ATA AAA TTG AAA TAT AGA TTGTGC GTC ATC CCT TAC GTC AGT GGA GAT-3′

The p74-309 sequence from the EcoRV site (GAT ATC) to the first codon(ATG) of GUS is shown below (TATA box—lower case in bold; two syntheticROS sequence—bold caps; a transcription start site—ACA, bold italics;BamHI site—GGA TCC; the first codon of GUS, ATG-italics, are alsoindicated): 5′-GAT ATC TCC ACT GAC GTA AGG GAT (SEQ ID NO:24) GAC GCACAA TCT ATA TTT CAA TTT TAT TGT AAT ATA Cta tat aAT ATA TTT CAA TTT TATTGT AAT ATA

    CGG GGG ACT CTA GAG GAT CCC CGG GTG GTC AGT CCC TTA TG-3′p76-508: Construct for The Expression of The GUS Gene Driven by the tms2Promoter Containing a ROS Operator (FIG. 4(B)).

The tms2 promoter is PCR amplified from genomic DNA of Agrobacteriumtumefaciens 33970 using the following primers: sense primer: 5′-TGC GGATGC ATA AGC TTG CTG ACA (SEQ ID NO:6) TTG CTA GAA AAG-3′ anti-senseprimer: 5′-CGG GGA TCC TTT CAG GGC CAT TTC (SEQ ID NO:7) AG-3′

The 352 bp PCR fragment is cloned into the EcoRV site of pBluescript,and sub-cloned into pGEM-7Zf(+). Two complementary oligos, ROS-OP1 (SEQID NO:15) and ROS-OP2 (SEQ ID NO:16), containing two ROS operators (initalics, below), are annealed together and cloned into pGEM-7Zf(+) as aBamHI/ClaI fragment at the 3′ end of the tms2 promoter. Thispromoter/operator fragment is then sub-cloned into pBI121 as aHindIII/XbaI fragment, replacing the CaMV 35S promoter fragment.ROS-OP1: 5′-GAT CCT ATA TTT CAA TTT TAT TGT (SEQ ID NO:15) AAT ATA GCTATA TTT CAA TTT TAT TGT AAT ATA AT-3′ ROS-OP2: 5′-CGA TTA TAT TAC AATAAA ATT GAA (SEQ ID NO:16) ATA TAG CTA TAT TAC AAT AAA ATT GAA ATA TAG-3′.

As a control, p76-507 comprising a tms2 promoter (without any operatorsequence) fused to GUS (FIG. 4(A)), is also prepared.

p74-501: Construct for The Expression of The GUS Gene Driven by TheActin2 Promoter Containing a ROS operator (FIG. 5(B)).

The Actin2 promoter is PCR amplified from genomic DNA of Arabidopsisthaliana ecotype Columbia using the following primers: Sense primer:(SEQ ID NO:17) 5′-AAG CTT ATG TAT GCA AGA GTC AGC-3′            SpeIAnti-sense primer: (SEQ ID NO:18) 5′-TTG ACT AGT ATC AGC CTC AGC CAT-3′The PCR fragment is cloned into pGEM-T-Easy. Two complementary oligos,ROS-OP1 (SEQ ID NO:15) and ROS-OP2 (SEQ ID NO:16), with built-in BamHIand ClaI sites, and containing two ROS operators, are annealed togetherand inserted into the Actin2 promoter at the BglII/Cla I sites replacingthe BglII/ClaI fragment. This modified promoter is inserted intopBI121vector as a HindIII/BamHI fragment.p74-118 Construct for The Expression of GUS Driven by a CaMV 35SPromoter Containing three ROS Operators Downstream of TATA Box (FIG.5(C)).

The BamHI-EcoRV fragment of CaMV 35S promoter in pBI121 is cut out andreplaced with a similar synthesized DNA fragment in which a regiondownstream of the TATA box was replaced with three ROS operatorsequences (SEQ ID NO:25). The first of the three synthetic ROS operatorsequences is positioned immediatlely of the TAT box, the other two ROSoperator sequence are located downstream of the trasncriptional startsite (ACA). Two complementary oligos with built-in BamHI-EcoRV ends wereprepared as describe above for the other constructs were annealedtogether and ligated into the BamHI-EcoRV sites of CaMV35S.

The p74-118 sequence from the EcoRV site (GATATC) to the first codon(ATG) of GUS is shown below (TATA box—lower case in bold; threesynthetic ROS sequence—bold caps; a transcription start site—ACA, bolditalics; BamHI site—GGATCC; the first codon of GUS, ATG-italics, arealso indicated): 5′-GAT ATC ee TCC ACT GAC GTA AGG GAT (SEQ ID NO:25)GAC GCA CAA TCC CAC TAT CCT TCG CAA GAC CCT TCC TCt ata taA TAT ATT TCAATT TTA TGG TAA TAT A

    CG GGG GAC TCT AGA GGA TCC TAT ATT TCA ATT TTA TTG TAA TAT AGC TATATT TCA ATT TTA TTG TAA TAT AAT CGA GGG CGA ACC CGG GGT ACC GAA TTC CTCGAG TCT AGA GGA TCC CCG GGT GGT CAG TCC CTT ATG-3′

As a control, p75-101, comprising an actin2 promoter (without anyoperator sequence) fused to GUS (FIG. 5(A)), is also prepared.

The various constructs are introduced into Arabidopsis, as describedabove, and transgenic plants are generated. Transformed plants areverified using PCR or Southern analysis. FIG. 6(A) show Southernanalysis of transgenic plants comprising a first genetic construct, forexample, p74-309 (35S-operator sequence-GUS, FIG. 3(C)).

GUS Expression Assays on Reporter Transgenic Lines

In order to assess the activity of the modified regulatory regions, thelevel of expression of the GUS gene is assayed. Leaf tissues(approximately 10 mg) from putative positive transformants are placedinto a microtitre plate containing 100 ul of GUS staining buffer (100 mMKPO₄, 1 mM EDTA, 0.5 mM K-ferricyanide, 0.5 mM K-ferrocyanide, 0.1%Triton X-100, 1 mM 5-bromo-4-chloro-3-indolyl glucuronide), andvacuum-infiltrated for one hour. The plate is covered and incubated at37° C. overnight. Tissues are destained when necessary using 95% ethanoland color reaction is evaluated either visually or with a microscope.

For the modified 35S promoter, 45 lines had high GUS expression levels.These include 15 lines containing the ROS operator upstream of the TATAbox, 24 lines containing the ROS operator downstream of the TATA box andsix lines containing the ROS operator upstream and downstream of theTATA box. Using the actin2 promoter, 8 lines containing the ROS operatordisplayed high levels of GUS activity. An example of GUS expression in aplant transformed with p74-501 (actin-ROS operator sequence:GUS), isshown in FIG. 8.

Single copy transformants expressing various levels of GUS activity areused for crossing with repressor lines prepared in Example 2, asoutlined in Example 4.

Example 4

Crossing of Transgenic Lines Containing ROS Repressor Constructs withTransgenic Lines Containing GUS Reporter Constructs.

Transgenic Arabidopsis lines containing repressor constructs (secondgenetic constructs) are crossed with lines containing appropriatereporter (GUS) constructs (first genetic constructs). To perform thecrossing, open flowers are removed from plants of the reporter lines.Fully formed buds of plants of the repressor lines are gently opened andemasculated by removing all stamens. The stigmas are then pollinatedwith pollen from plants of the repressor lines and pollinated buds aretagged and bagged. Once siliques formed, the bags are removed, andmature seeds are collected. Plants generated from these seeds are thenused to determine the level of reporter gene (GUS) repression by GUSstaining. Levels of GUS expression in the hybrid lines are compared tothose of the original reporter lines. Plants showing a decrease in GUSexpression levels are further characterized using PCR, Southern andNorthern analysis.

Results of a cross between a transgenic line expressing synthetic ROS(p74-101-FIG. 2D) and GUS (p74-118 (FIG. 5C) are presented in FIG. 9.

GUS activity (FIG. 9A) is only observed in plants expressing GUS (termedGUS parent in FIG. 9, expressing p74-118). The plant expressing ROS (ROSparent, expressing p74-101) exhibited no GUS expression. This result isas expected, since this plant is not transformed with the GUS construct.Of interest, however, is that the plant produced as a result of a crossbetween the GUS and ROS parents did not exhibit GUS activity.

Northern analysis (FIG. 9B) demonstrates that GUS expression isconsistent with the GUS assay (FIG. 9A), in that oily the GUS parentexpressed GUS RNA, while no GUS expression was observed in the ROSparent or the progeny arising from a cross between the ROS and GUSparents. Similarly, as expected, no ROS expression was detected in theGUS parent. ROS expression was observed in the ROS parent and in thecross between the ROS and GUS parents.

Southern analysis of the progeny of the cross between the GUS and ROSparents demonstrates that the cross comprised genes encoding both. GUSand ROS (FIG. 9C).

These data demonstrate ROS repression of a gene of interest. The progenyof the cross between the ROS and GUS parent lines, comprising both theGUS and ROS gene, expresses the ROS repressor, which binds the operatorsequence thereby inhibiting the expression of the gene of interest, inthis case GUS. Inhibition of GUS expression was observed at the RNA andprotein levels, and no enzyme activity was present in the progenyplants.

FIGS. 1A-D, shows results of the crosses described in Table 5, between arange of repressor and reporter plants (plants expressing Tag protein).Maps of the constructs listed in Table 5 are shown in FIGS. 10A and B.TABLE 5 Crossing of lines expressing reporter lines expressing a proteinof interest with plant lines expressing the repressor protein ConstructsParental lines Crosses Female X male Female X male parent Cross1(C1)74-316 X 74-101 P1GUS X P1ROS Cross2(C2) 74-101 X 74-117 P2ROS X P2GUSCross3(C3) 74-118 X 74-101 P3GUS X P3ROS Cross4(C4) 74-117 X 74-101P2GUS X P2ROS

Northern blot analysis of total RNA (˜4.5 g) isolated from Arabidopsisparental lines including reporter plants expressing a protein ofinterest, in this example GUS, and crosses between the parental lines asindicated in Table 5 was performed. Results of these analysis is shownin FIGS. 11A-D. The results of GUS expression using GUS as a probe forcrosses C1-C5 are shown in FIG. 11A. Results of ROS expression, usingROS as a probe for crosses C1-C5 are shown in FIG. 11B. FIG. 11C showsthe loading of the RNA gel, and FIG. 11D shows quantification of thedensities of the bands generated in the Northern analysis of FIG. 11Ausing a GUS probe.

The parental lines expressing ROS, and all of the crosses that were madeto ROS exhibited ROS expression as indicated in FIG. 11B. No ROSexpression is observed in parental lines expressing GUS since theselines do not comprise a ROS construct. With reference to FIG. 11A, GUSmaximal expression is observed in parental lines expressing the reporterconstruct (GUS P1-P3 and P5); however, a range of reduced GUS activityis observed in plants that were crossed (lanes marked C1-C5) with aplants expressing a repressor construct. The range of reduced GUSactivity varied with reduction of the maximal. GUS activity observed inlines C2D and C2G.

In FIG. 11D, lanes P1 GUS, P2 GUS, P3 GUS, P4 GUS, P5 GUS, exhibit GUSexpression of the parent expressing the first nucleotide sequence (i.e.p74-316, p74-117, p74-118, p74-117 and p74-501, respectively). Theseplants exhibit maximum expression of GUS RNA. Lanes P1 ROS, P2 ROS, P3ROS, P4 ROS (comprising p74-101 or p74-313) exhibit background levels ofGUS RNA, as these plants do not comprise any sequence resulting in GUSexpression. Progeny of all crosses between plants expressing the firstnucleotide sequence (p74-316, p74-117, p74-118, p74-117 and p74-501) andplants expressing the second nucleotide sequence (p74-101 or p74-313)resulted in reduced expression of GUS (the first coding region, 30) offrom about 30% (e.g. for C1A) to about 90% (for C2G).

These results show that expression of a protein of interest can becontrolled using the repressor mediated system as described herein.

FIG. 13 represents a northern analysis of plants obtained from crossingtransgenic Brassica lines containing repressor constructs (secondgenetic constructs) with lines containing appropriate reporter (GUS)constructs (first genetic constructs). Agrobacterium-mediatedtransformation of B. napus was carried out as described in Moloney etal., Plant Cell Rep. 8:238-242 (1989) with modifications. Seeds weresterilized and then plated on ½ strength hormone-free MS medium (Sigma)with 1% sucrose in 15×60 mm petri dishes. Seeds were then transferred,with the lid removed, into Magenta GA-7 vessels (temperature of 25degrees C., with 16 h light/8 h dark and a light intensity of 70-80microE.

Cotyledons were excised from 4-day old seedlings and soaked in BASEsolution (4.3 g/L MS (GIBCO BRL), 10 ml 100× B5 Vitamins (0.1 g/Lnicotinic acid, 1.0 g/L thiamine-HCl, 0.1 g/L pyridoxine-HCl, 10 g/Lm-inositol), 2% sucrose, 1 mg/L 2,4-D, pH 5.8; 1% DMSO and 200 microMacetosyringone added after autoclaving) containing Agrobacterium cellscomprising a recombinant plant transformation vector. Most of the BASEsolution was removed and the cotyledons were incubated at 28 degrees C.for 2 days in the dark. The dishes containing the cotyledons were thentransferred to 4 degrees C. for 3-4 days in the dark. Cotyledons weretransferred to plates containing MS B5 selection medium (4.3 g/L MS, 10ml 100× B5 Vitamins, 3% sucrose, 4 mg/L benzyl adenine (BA) ph 5.8;timentin (300 Fg/ml) and kanamycin (20 Fg/ml) were added afterautoclaving) and left at 25 degrees C., 16 h light/8 dark with lightingto 70-100 microE. Shoots were transferred to Magenta GA-7 vesselscontaining MS B5 selection medium without BA. When shoots weresufficiently big they were transferred to Magenta GA-7 vesselscontaining rooting medium and upon development of a good root systemplantlets were removed from the vessels and transferred to moist pottingsoil.

The genetic constructs that were used to transform parental cell lineswere p74-114 and p74-101. As shown in FIG. 12B p74-114 is a constructcomprising a region encoding GUS operatively linked to a CaMV 35Sregulatory region containing one ROS operator sequence upstream andthree ROS operator sequences downstream of TATA Box.

p74-114: Construct for The Expression of GUS Driven by a CaMV 35SPromoter Containing One ROS Operator Upstream and Three ROS OperatorsDownstream of TATA Box:

In order to construct p74-114 (see FIG. 12B) the BamHI-EcoRV fragment ofCaMV 35S promoter in pBI121 is cut out and replaced with a similarsynthesized DNA fragment in which a region upstream and downstream ofthe TATA box was replaced with four ROS operator sequences (SEQ IDNO:8). The first of the four synthetic ROS operator sequences ispositioned 25 bp immediately upstream of the TATA box. The second of thefour synthetic ROS operator sequences is positioned 25 bp immediatelydownstream of the TATA box. The other two ROS operator sequences arelocated downstream of the transcriptional start site (ACA). Twocomplementary oligos (SEQ ID NO:13 and 14) with built-in BamHI-EcoRVends were prepared as described above for the other constructs, wereannealed together and ligated into the BamHI-EcoRV sites of CaMV 35S.The p74-114 sequence from the EcoRV site (GAT ATC) to the first codon(ATG) of GUS is shown below (SEQ ID NO:45); TATA box—lower case in bold:the synthetic ROS sequence—bold caps; a transcription start site—ACA,bold italics: BamHI site—GGA TCC; the first codon of GUS, ATG—italics,are also indicated); 5′ GAT ATC TCC ACT GAC GTA AGG GAT (SEQ ID NO:45)GAC GCA CAA TCT ATA TTT CAA TTT TAT TGT AAT ATA Cta tat aAT ATA TTT CAATTT TAT TGT AAT ATA     CGG GGG ACT CTA GAG GAT CC T ATA TTT CAA TTT TATTGT AAT ATA GCT ATA TTT CAA TTT TAT TGT AAT ATA ATC GAT TTC GAA CCC GGGGTA CCG AAT TCC TCG AGT CTA GAG GAT CCC CGG GTG GTC AGT CCC TTA TG-3′

The engineering of the p74-101 (FIG. 12A) construct for synROSexpression under actin2 promoter has been described above in Example 2.

Parental Brassica napus lines separately comprising p74-101 or p74-114are crossed to produce hybrid lines comprising both p74-101 and p4-114.Crosses performed are as follows: C1 and C2 are p74-114x p74-101. P1GUSis the GUS parent plant for C1. P2GUS is GUS parent plant for C2. PROSis ROS parent plant for crosses C1 and C2. Levels of GUS expression inthe hybrid lines are compared to those of the original parent lines bynorthern analysis as shown in FIG. 13. FIG. 13 demonstrates that highGUS expression, greater than 100, only occurs in the GUS parental lineP1GUS, while no GUS expression was observed in the ROS parent PROS, andGUS expression is reduced in progeny arising from a cross between theROS and GUS parents, C1 and C2. Similarly, as expected, no ROSexpression was detected in the GUS parental lines, P1GUS and P2GUS. ROSexpression was observed in the ROS parent and in the cross between theROS and GUS parents.

These data further demonstrate ROS repression of a gene of interest inBrassicacae. The progeny of the cross between the ROS and GUS parentlines, comprising both the GUS and ROS gene, expresses the ROSrepressor, which binds the operator sequence thereby inhibiting theexpression of the gene of interest, in this case GUS.

These data demonstrate that expression of a gene of interest can becontrolled using the repressor mediated system as described herein.

All citations are herein incorporated by reference.

The present invention has been described with regard to preferredembodiments. However, it will be obvious to persons skilled in the artthat a number of variations and modifications can be made withoutdeparting from the scope of the invention as described herein.

1. A nucleic acid molecule, or a derivative thereof, encoding a ROSrepressor optimized for plant codon usage and exhibiting ROS operatorbinding activity, ROS repressor activity, or both ROS operator bindingactivity and ROS repressor activity.
 2. The nucleic acid molecule ofclaim 1, wherein said nucleic acid molecule, or a derivative thereof,comprises greater than 80% similarity with the nucleotide sequenceselected from the group consisting of SEQ ID NO:2, and SEQ ID NO:3 asdetermined by use of the BLAST algorithm with the following parameters:blastn; Database: nr; Expect 10; filter: low completity; Alignment:pairwise; Wordsize
 11. 3. The nucleic acid molecule of claim 1, whereinsaid nucleic acid molecule, or a derivative thereof, hybridizes understringent conditions with the nucleotide sequence selected from thegroup consisting of SEQ ID NO:2, and SEQ ID NO:3, said stringentconditions comprising, hybridizing for 16-20 hrs at 65° C. in 7% SDS, 1mM EDTA, 0.5 M Na ₂HPO₄, pH 7.2, followed by washing in 5% SDS, 1 mMEDTA 40 mM Na₂HPO₄, pH 7.2 for 30 min, followed by washing in 1% SDS, 1mM EDTA 40 mM Na₂HPO₄, pH 7.2 for 30 min.
 4. The nucleic acid moleculeof claim 1 wherein said nucleic acid molecule comprises the nucleotidesequence of SEQ ID NO:
 2. 5. A genetic construct comprising a regulatoryregion in operative association with the nucleic acid molecule ofclaim
 1. 6. The nucleic acid molecule of claim 1, further comprising anucleic acid sequence encoding a nuclear localization signal fused tosaid nucleic acid molecule.
 7. The genetic construct of claim 5, furthercomprising a nucleic acid sequence encoding a nuclear localizationsignal fused to said nucleic acid molecule.
 8. A plant comprising thegenetic construct of claim
 5. 9. A plant comprising the geneticconstruct of claim
 7. 10. A seed comprising the genetic construct ofclaim
 5. 11. A seed comprising the genetic construct of claim
 7. 12-15.(canceled)
 16. A plant comprising; i) a first genetic constructcomprising a genetic construct comprising a regulatory regionoperatively linked to a gene of interest and one, or more than one, ROSoperator sequence capable of controlling the activity of said regulatoryregion, wherein said regulatory region is functional in plants, and ii)a second genetic construct comprising a regulatory region in operativeassociation with a nucleic acid molecule, or a derivative thereof, saidnucleic acid or derivative thereof encoding said ROS repressor ofclaim
 1. 17. The plant as defined in claim 16, wherein said secondgenetic construct further comprises a nuclear localization signal fusedto said nucleic acid molecule or derivative thereof.
 18. The plant ofclaim 16, wherein said gene of interest encodes a protein selected fromthe group consisting of one or more enzymes involved in fiberbiosynthesis, one or more enzymes involved in glucosinolatebiosynthesis, one or more enzymes involved in phytotoxin biosynthesis,caffeic o-methyltransferase, indole acetamide hydrolase, andphosphinothricin acetyl transferase. 19-20. (canceled)
 21. A method forselectively controlling the transcription of a gene of interest in aplant, comprising: i) introducing into said plant: a) a first geneticconstruct comprising a nucleic acid molecule comprising a firstregulatory region operatively linked to a gene of interest, and one, ormore than one, ROS operator sequence capable of controlling the activityof said first regulatory region; and b) a second genetic constructcomprising a second regulatory region in operative association with anucleotide sequence encoding a ROS repressor, or a derivative thereof,said ROS repressor exhibiting both ROS operator binding activity and ROSrepressor activity; said second regulatory region comprises an induciblepromoter; ii) growing said plant, and iii) inducing the activity of saidinducible promoter so that expression of said second genetic constructproduces said ROS repressor and represses expression of said gene ofinterest. 22-23. (canceled)
 24. A method for selectively controlling thetranscription of a gene of interest, comprising: i) producing a firstplant comprising a first genetic construct, said first genetic constructcomprising a first regulatory region operatively linked to a gene ofinterest and one, or more than one, repressor operator sequence capableof controlling the activity of said first regulatory region; ii)producing a second plant comprising a second genetic construct, saidsecond genetic construct comprising a second regulatory region inoperative association with a nucleic the molecule, or a derivativethereof, encoding a repressor, said repressor exhibiting both repressoroperator binding activity and repressor activity, and said repressoroptimized for plant expression; iii) crossing said first plant and saidsecond plant to obtain progeny, said progeny comprising both said firstgenetic construct and said second genetic construct, and characterizedin that expression of said second genetic construct represses expressionof said gene of interest. 25-26. (canceled)
 27. The nucleic acidmolecule of claim 1 wherein said nucleic acid molecule comprises thenucleotide sequence of SEQ ID NO:3.
 28. A vector comprising; i) a firstgenetic construct comprising a first nucleic acid molecule comprising afirst regulatory region operatively linked to a gene of interest andone, or more than one, ROS operator sequence capable of controlling theactivity of said first regulatory region, wherein said first regulatoryregion is functional in plants; and ii) a second genetic constructcomprising a second regulatory region in operative association with asecond nucleic acid molecule, or a derivative thereof, said secondnucleic acid or derivative thereof encoding said ROS repressor ofclaim
 1. 29. The vector as defined in claim 28, wherein said secondgenetic construct further comprises a nuclear localization signal fusedto said second nucleic acid molecule or derivative thereof.
 30. Thevector of claim 28, wherein said first and second regulatory regions areeither the same or different and are selected from the group consistingof a constitutive promoter, an inducible promoter, a tissue specificpromoter, and a developmental promoter.
 31. A plant comprising thevector of claim
 29. 32. A plant comprising the vector of claim 30.33-34. (canceled)
 35. The nucleic acid molecule of claim 1 wherein saidnucleic acid molecule comprises the nucleotide sequence of SEQ ID NO:3.36. The plant of claim 16, wherein said at least one ROS operatorsequence comprises the nucleotide sequence of SEQ ID NO:20.
 37. Theplant as defined in claim 8, wherein said plant is selected from thegroup consisting of canola, Brassica spp., maize, tobacco, alfalfa,potato, ginseng, pea, oat, rice, soybean, wheat, barley, sunflower, andcotton.
 38. The plant as defined in claim 9, wherein said plant isselected from the group consisting of canola, Brassica spp., maize,tobacco, alfalfa, potato, ginseng, pea, oat, rice, soybean, wheat,barley, sunflower, and cotton.